00000000|MMI|9.79|Pulmonary Edema|C0034063|[dsyn]|["PULMONARY OEDEMA"-tx-1-"pulmonary edema"-noun-0]|TX|71/15|C08.381.742
00000000|MMI|5.18|Flash|C0262485|[diap]|["Flash"-tx-1-"flash"-verb-0]|TX|65/5|
00000000|MMI|5.18|Light Sources, Flash|C0181637|[medd]|["flash"-tx-1-"flash"-verb-0]|TX|65/5|
00000000|MMI|3.65|Admission date:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative|C2598112|[clna]|["Admission date"-tx-1-"Admission Date"-noun-0]|TX|97/14|
00000000|MMI|3.65|Date of admission|C1302393|[tmco]|["Admission date"-tx-1-"Admission Date"-noun-0]|TX|97/14|
00000000|MMI|3.65|Report status|C0586177|[fndg]|["Report status"-tx-1-"Report Status"-noun-0]|TX|123/13|
00000000|MMI|3.59|Pyrexia of unknown origin (excl puerperal)|C0856281|[sosy]|["puo"-tx-1-"PUO"-noun-0]|TX|12/3|
00000000|MMI|3.46|+5|C0728893|[qnco]|["+5"-tx-1-"5"-fraction-0]|TX|113/1|
00000000|MMI|3.46|>5|C0439084|[qnco]|[">5"-tx-1-"5"-fraction-0]|TX|113/1|
00000000|MMI|3.46|Diagnostic interview schedule|C0451119|[inpr]|["DIS"-tx-1-"DIS"-noun-0]|TX|91/3|
00000000|MMI|3.46|Discontinued|C1444662|[fndg]|["DIS"-tx-1-"DIS"-noun-0]|TX|91/3|
00000000|MMI|130.20|Portugal|C0032729|[geoa]|["PO"-tx-37-"PO"-noun-0,"PO"-tx-27-"po"-noun-0,"PO"-tx-21-"PO"-noun-0,"PO"-tx-17-"PO"-noun-0,"PO"-tx-16-"PO"-noun-0,"PO"-tx-13-"PO"-noun-0,"PO"-tx-10-"PO"-noun-0,"PO"-tx-7-"PO"-noun-0,"PO"-tx-5-"PO"-noun-0,"PO"-tx-2-"PO"-noun-0]|TX|6153/2;4299/2;2203/2;1974/2;[1607/2],[1785/2];1359/2;[1121/2],[1162/2];[714/2],[850/2],[923/2];600/2;373/2|Z01.542.727
00000000|MMI|129.73|Override|C1547671|[acty]|["Override"-tx-21-"override"-verb-0,"Override"-tx-17-"Override"-verb-0,"Override"-tx-17-"overridden"-noun-0,"Override"-tx-16-"override"-verb-0,"Override"-tx-14-"Override"-verb-0,"Override"-tx-14-"override"-verb-0,"Override"-tx-11-"Override"-verb-0,"Override"-tx-10-"override"-verb-0,"Override"-tx-7-"Override"-verb-0,"Override"-tx-7-"overridden"-noun-0,"Override"-tx-7-"override"-verb-0,"Override"-tx-5-"Override"-verb-0,"Override"-tx-5-"override"-verb-0,"Override"-tx-2-"Override"-verb-0,"Override"-tx-2-"overridden"-noun-0]|TX|2154/8;2001/8;1989/10;1708/8;1519/8;[1469/8],[1497/8];[1255/8],[1272/8];1084/8;950/8;938/10;804/8;[609/8],[626/8];525/8;400/8;388/10|
00000000|MMI|119.81|Patient Discharge|C0030685|[hlca]|["Discharge"-tx-55-"DISCHARGE"-noun-0,"Discharge"-tx-51-"DISCHARGE"-noun-0,"Discharge"-tx-38-"discharge"-noun-0,"Discharge"-tx-36-"discharge"-noun-0,"Discharge"-tx-22-"DISCHARGE"-noun-0,"Discharge"-tx-2-"DISCHARGE"-verb-0,"Discharge"-tx-1-"DISCHARGE"-noun-0,"Patient Discharge"-tx-1-"DISCHARGE PATIENT"-noun-0]|TX|7850/9;7383/9;6182/9;6080/9;2612/9;331/9;39/9;110/17|E02.204.125;E02.760.400.610;N02.421.192.125;N02.421.585.400.610;N04.590.233.727.210.125
00000000|MMI|115.15|Hippocampus Proper|C3887642|[bpoc]|["CA"-tx-42-"Ca"-noun-0,"CA"-tx-29-"Ca"-noun-0,"CA"-tx-26-"CA"-adj-0,"CA"-tx-22-"Ca"-noun-0,"CA"-tx-22-"ca"-adj-0,"CA"-tx-22-"ca"-noun-0]|TX|6789/2;5198/2;4090/2;3564/2;[3004/2],[3098/2];[3004/2],[3098/2]|A08.186.211.464.405;A08.186.211.730.885.287.500.345
00000000|MMI|100.84|Coumadin|C0699129|[orch,phsu]|["Coumadin"-tx-51-"coumadin"-noun-0,"Coumadin"-tx-46-"coumadin"-noun-0,"Coumadin"-tx-27-"coumadin"-noun-0,"Coumadin"-tx-16-"COUMADIN"-noun-0,"Coumadin"-tx-7-"COUMADIN"-noun-0]|TX|7502/8;[7000/8],[7054/8];4236/8;1598/8;705/8|D03.383.663.283.446.520.914;D03.438.150.446.520.914
00000000|MMI|85.76|Dominican Republic|C0013014|[geoa]|["DR"-tx-51-"Dr"-noun-0,"DR"-tx-49-"Dr"-noun-0,"DR"-tx-47-"Dr"-noun-0,"DR"-tx-43-"Dr"-noun-0,"DR"-tx-39-"Dr"-noun-0,"DR"-tx-21-"DR"-noun-0,"DR"-tx-21-"Dr"-noun-0]|TX|7557/2;7311/2;7239/2;6838/2;6436/2;2412/2;2490/2|Z01.107.084.900.300;Z01.639.880.300
00000000|MMI|84.89|Aspirin|C0004057|[orch,phsu]|["ASA"-tx-32-"ASA"-noun-0,"ASA"-tx-27-"asa"-noun-0,"ASPIRIN"-tx-7-"ASPIRIN"-noun-0,"ASPIRIN"-tx-5-"ASPIRIN"-noun-0]|TX|5399/3;4227/3;770/7;569/7|D02.455.426.559.389.657.410.595.176
00000000|MMI|71.41|Lasix|C0699992|[orch,phsu]|["Lasix"-tx-52-"lasix"-noun-0,"Lasix"-tx-27-"lasix"-noun-0,"Lasix"-tx-23-"lasix"-noun-0,"Lasix"-tx-22-"lasix"-noun-0,"Lasix"-tx-7-"LASIX"-noun-0]|TX|7610/5;4263/5;3742/5;3599/5;823/5|D02.065.884.725.300;D02.092.146.807.300;D02.886.590.700.725.300
00000000|MMI|68.99|Physicians|C0031831|[prog]|["DR"-tx-51-"Dr"-noun-0,"DR"-tx-49-"Dr"-noun-0,"DR"-tx-47-"Dr"-noun-0,"DR"-tx-43-"Dr"-noun-0,"DR"-tx-39-"Dr"-noun-0,"DR"-tx-21-"DR"-noun-0,"DR"-tx-21-"Dr"-noun-0]|TX|7557/2;7311/2;7239/2;6838/2;6436/2;2412/2;2490/2|M01.526.485.810;N02.360.810
00000000|MMI|65.65|Warfarin|C0043031|[hops,orch,phsu]|["WARFARIN"-tx-16-"WARFARIN"-noun-0,"WARFARIN"-tx-10-"WARFARIN"-noun-0,"WARFARIN"-tx-7-"WARFARIN"-noun-0,"WARFARIN"-tx-5-"WARFARIN"-noun-0]|TX|1688/8;1037/8;784/8;487/8|D03.383.663.283.446.520.914;D03.438.150.446.520.914
00000000|MMI|59.51|Diabetes Mellitus, Non-Insulin-Dependent|C0011860|[dsyn]|["MOD"-tx-29-"mod"-noun-0,"MOD"-tx-28-"mod"-noun-0,"MOD"-tx-26-"mod"-noun-0]|TX|[5041/3],[5145/3];[4623/3],[4655/3];4007/3|C18.452.394.750.149;C19.246.300
00000000|MMI|58.08|Awareness|C0004448|[menp]|["Aware"-tx-21-"aware"-adj-0,"Aware"-tx-16-"aware"-adj-0,"Aware"-tx-14-"aware"-adj-0,"Aware"-tx-10-"aware"-adj-0,"Aware"-tx-7-"aware"-adj-0,"Aware"-tx-5-"aware"-adj-0]|TX|2167/5;1721/5;1482/5;1097/5;817/5;538/5|F02.463.188.150
00000000|MMI|52.60|Cardiac Surgery procedures|C0018821|[topp]|["Cardiac surgery"-tx-52-"cardiac surgery"-noun-0,"Cardiac surgery"-tx-51-"cardiac surgery"-noun-0,"Cardiac surgery"-tx-47-"cardiac surgery"-noun-0,"Cardiac surgery"-tx-46-"cardiac surgery"-noun-0,"Cardiac surgery"-tx-40-"Cardiac Surgery"-noun-0,"Cardiac surgery"-tx-39-"cardiac surgery"-noun-0]|TX|[7573/15],[7723/15];7530/15;7199/15;7089/15;6453/15;6213/15|E04.100.376;E04.928.220
00000000|MMI|49.02|Coding|C0009219|[ocac]|["code"-tx-47-"CODE"-noun-0,"code"-tx-2-"CODE"-noun-0,"code"-tx-2-"code"-noun-0]|TX|7119/4;278/4;296/4|N04.452.758.708.200.400.500;N04.452.859.564.274;N05.715.360.300.715.500.249;N06.850.520.308.940.968.249
00000000|MMI|49.01|Pravastatin Sodium|C0700474|[orch,phsu]|["PRAVASTATIN SODIUM"-tx-20-"PRAVASTATIN SODIUM"-noun-0,"PRAVASTATIN SODIUM"-tx-16-"PRAVASTATIN SODIUM"-noun-0,"PRAVASTATIN SODIUM"-tx-13-"PRAVASTATIN SODIUM"-noun-0]|TX|2100/18;1663/18;1415/18|D02.455.426.559.847.638.930;D04.615.638.930
00000000|MMI|47.79|Mongolia|C0026410|[geoa]|["MG"-tx-27-"mg"-noun-0,"MG"-tx-16-"MG"-noun-0,"MG"-tx-10-"MG"-noun-0,"MG"-tx-7-"MG"-noun-0,"MG"-tx-5-"MG"-noun-0]|TX|4373/2;1782/2;1159/2;847/2;597/2|Z01.252.474.651
00000000|MMI|46.09|Oral|C0442027|[spco]|["PO"-tx-37-"PO"-noun-0,"PO"-tx-27-"po"-noun-0,"PO"-tx-21-"PO"-noun-0,"PO"-tx-17-"PO"-noun-0,"PO"-tx-16-"PO"-noun-0,"PO"-tx-13-"PO"-noun-0,"PO"-tx-10-"PO"-noun-0,"PO"-tx-7-"PO"-noun-0,"PO"-tx-5-"PO"-noun-0,"PO"-tx-2-"PO"-noun-0]|TX|6153/2;4299/2;2203/2;1974/2;[1607/2],[1785/2];1359/2;[1121/2],[1162/2];[714/2],[850/2],[923/2];600/2;373/2|
00000000|MMI|42.59|Nexium|C0939400|[orch,phsu]|["Nexium"-tx-46-"nexium"-noun-0,"Nexium"-tx-27-"nexium"-noun-0,"Nexium"-tx-21-"NEXIUM"-noun-0]|TX|6987/6;4343/6;2173/6|D02.886.640.074.500.500;D03.383.725.024.500.500;D03.438.103.034.500.500
00000000|MMI|42.27|International Normalized Ratio|C0525032|[lbpr]|["INR"-tx-46-"INR"-noun-0,"INR"-tx-29-"INR"-noun-0]|TX|[6938/3],[7013/3];5086/3|E01.370.225.625.115.320;E05.200.625.115.320
00000000|MMI|39.46|Date Fruit|C2348077|[food]|["DATE"-tx-48-"date"-noun-0,"DATE"-tx-39-"date"-noun-0]|TX|7293/4;6321/4|B01.650.940.800.575.100.093.615
00000000|MMI|38.84|Niacin|C0027996|[phsu,vita]|["NIACIN"-tx-20-"NIACIN"-noun-0,"NICOTINIC ACID"-tx-17-"NICOTINIC ACID"-noun-0,"NIACIN"-tx-13-"NIACIN"-noun-0]|TX|2125/6;1932/14;1440/6|D03.066.515.475;D03.383.725.547.475
00000000|MMI|38.84|Togo|C0040363|[geoa]|["TO"-tx-48-"to"-adv-0,"TO"-tx-41-"to"-adv-0,"TO"-tx-21-"to"-adv-0]|TX|7279/2;6586/2;2452/2|Z01.058.290.190.800
00000000|MMI|38.84|Tryptophanase|C0041260|[aapp,enzy]|["TO"-tx-48-"to"-adv-0,"TO"-tx-41-"to"-adv-0,"TO"-tx-21-"to"-adv-0]|TX|7279/2;6586/2;2452/2|D08.811.520.224.800
00000000|MMI|38.28|BaseLine dental cement|C0168634|[bodm]|["baseline"-tx-42-"baseline"-noun-0,"baseline"-tx-31-"Baseline"-noun-0,"baseline"-tx-26-"baseline"-noun-0,"baseline"-tx-25-"baseline"-noun-0]|TX|6707/8;5329/8;4122/8;3838/8|x.x.x.x
00000000|MMI|38.14|Dyspnea|C0013404|[sosy]|["SOB"-tx-52-"SOB"-noun-0,"DYSPNOEA"-tx-23-"dyspnea"-noun-0,"SOB"-tx-23-"SOB"-noun-0,"DYSPNOEA"-tx-22-"dyspnea"-noun-0]|TX|7632/3;3705/7;3699/3;3633/7|C08.618.326;C23.888.852.371
00000000|MMI|35.21|Ivory Coast|C0022326|[geoa]|["IV"-tx-29-"IV"-noun-0,"IV"-tx-26-"IV"-noun-0,"IV"-tx-22-"IV"-noun-0]|TX|5174/2;4146/2;3575/2|Z01.058.290.190.272
00000000|MMI|34.90|diagnosis aspect|C1704338|[qlco]|["diagnosis"-tx-22-"DIAGNOSIS"-noun-0]|TX|[2575/9],[2709/9]|x.x.x.x.x.x.x
00000000|MMI|33.68|Hypertensive disease|C0020538|[dsyn]|["HTN"-tx-41-"HTN"-noun-0,"HTN"-tx-26-"HTN"-noun-0,"HTN"-tx-22-"htn"-noun-0,"HYPERTENSION"-tx-22-"hypertension"-noun-0]|TX|6600/3;4042/3;2851/3;2857/12|C14.907.489
00000000|MMI|32.94|Cerebroside-Sulfatase|C0007804|[aapp,enzy]|["ASA"-tx-32-"ASA"-noun-0,"ASA"-tx-27-"asa"-noun-0]|TX|5399/3;4227/3|D08.811.277.352.827.070.250
00000000|MMI|32.84|10%|C3842590|[fndg]|["10%"-tx-55-"10"-fraction-0,"10%"-tx-33-"10"-fraction-0,"10%"-tx-29-"10"-fraction-0,"10%"-tx-17-"10"-fraction-0,"10%"-tx-14-"10"-fraction-0,"10%"-tx-11-"10"-fraction-0,"10%"-tx-7-"10"-fraction-0,"10%"-tx-5-"10"-fraction-0,"10%"-tx-2-"10"-fraction-0,"10%"-tx-1-"10"-fraction-0]|TX|7817/2;5441/2;[4902/2],[5021/2];2019/2;1537/2;1290/2;968/2;644/2;418/2;132/2|
00000000|MMI|32.76|Surgical aspects|C0038895|[ftcn]|["surgery"-tx-39-"surgery"-noun-0,"operations"-tx-22-"OPERATIONS"-noun-0]|TX|6261/7;3267/10|x.x.x.x.x.x.x
00000000|MMI|32.65|Pravachol|C0700763|[orch,phsu]|["Pravachol"-tx-27-"pravachol"-noun-0,"Pravachol"-tx-10-"PRAVACHOL"-noun-0]|TX|4212/9;1130/9|D02.455.426.559.847.638.930;D04.615.638.930
00000000|MMI|32.05|Doctor of Medicine|C1512018|[inpr]|["M.D."-tx-53-"M.D"-noun-0,"M.D."-tx-18-"M.D"-noun-0,"M.D."-tx-15-"M.D"-noun-0,"M.D."-tx-12-"M.D"-noun-0,"M.D."-tx-8-"M.D"-noun-0,"M.D."-tx-6-"M.D"-noun-0,"M.D."-tx-3-"M.D"-noun-0,"M.D."-tx-1-"M.D"-noun-0]|TX|7794/3;2054/3;1572/3;1325/3;1003/3;679/3;453/3;273/3|
00000000|MMI|31.94|Daily|C0332173|[tmco]|["QD"-tx-51-"qd"-noun-0,"/day"-tx-38-"day"-noun-0,"QD"-tx-37-"qd"-noun-0,"Daily"-tx-21-"DAILY"-adj-0,"Daily"-tx-17-"DAILY"-adv-0,"Daily"-tx-16-"DAILY"-adj-0,"Daily"-tx-10-"DAILY"-adj-0,"Daily"-tx-7-"DAILY"-adv-0,"Daily"-tx-5-"DAILY"-adj-0,"Daily"-tx-2-"DAILY"-adv-0]|TX|7489/2;6175/3;6150/2;2206/5;1977/5;1788/5;1124/5;[853/5],[926/5];603/5;376/5|
00000000|MMI|30.33|Gastroesophageal reflux disease|C0017168|[dsyn]|["GERD"-tx-22-"gerd"-noun-0,"Gastrooesophageal reflux disease"-tx-22-"gastroesophageal reflux disease"-noun-0]|TX|2897/4;2904/31|C06.405.117.119.500.484
00000000|MMI|29.32|Pulmonary Edema|C0034063|[dsyn]|["PULMONARY OEDEMA"-tx-35-"pulmonary edema"-noun-0,"PULMONARY OEDEMA"-tx-22-"pulmonary edema"-noun-0]|TX|5883/15;[2586/15],[2687/15],[3249/15]|C08.381.742
00000000|MMI|28.82|Stent, device|C0038257|[medd]|["Stents"-tx-26-"stents"-noun-0,"stenting"-tx-26-"stenting"-noun-0,"Stent"-tx-22-"stent"-noun-0,"Stents"-tx-22-"stents"-noun-0]|TX|3985/6;4071/8;3188/5;3434/6|E07.695.750
00000000|MMI|28.82|Solomon Islands|C0037623|[geoa]|["BP"-tx-41-"BP"-noun-0,"BP"-tx-24-"BP"-noun-0]|TX|[6527/2],[6562/2];3779/2|Z01.639.760.590
00000000|MMI|28.79|Costa Rica|C0010182|[geoa]|["CRI"-tx-42-"CRI"-noun-0,"CRI"-tx-26-"CRI"-noun-0,"CRI"-tx-22-"CRI"-noun-0]|TX|6716/3;4118/3;3126/3|Z01.107.169.238
00000000|MMI|28.52|Diet|C0012155|[food]|["Diet"-tx-21-"DIET"-noun-0]|TX|[2234/4],[2258/4],[2325/4]|G07.203.650.240
00000000|MMI|28.26|Panama|C0030266|[geoa]|["PM"-tx-55-"PM"-noun-0,"PM"-tx-36-"pm"-adj-0,"PM"-tx-1-"PM"-adj-0]|TX|7833/2;6014/2;149/2|Z01.107.169.772
00000000|MMI|28.09|Endometrial Carcinoma|C0476089|[neop]|["ENDOMETRIAL CANCER"-tx-22-"endometrial cancer"-noun-0,"Endometrial Ca"-tx-22-"endometrial ca"-adj-0]|TX|3066/18;3037/14|C04.588.945.418.948.585;C13.351.500.852.762.200;C13.351.937.418.875.200
00000000|MMI|28.01|District of Columbia|C0012764|[geoa]|["D.C."-tx-51-"d/c"-noun-0,"D.C."-tx-1-"D/C"-noun-0]|TX|7425/3;194/3|Z01.107.567.875.500.210;Z01.433.429
00000000|MMI|27.56|Doctor of Philosophy|C1512022|[inpr]|["Ph.D."-tx-54-"PH.D"-noun-0,"Ph.D."-tx-19-"PH.D"-noun-0,"Ph.D."-tx-16-"PH.D"-noun-0,"Ph.D."-tx-13-"PH.D"-noun-0,"Ph.D."-tx-9-"PH.D"-noun-0,"Ph.D."-tx-7-"PH.D"-noun-0,"Ph.D."-tx-4-"PH.D"-noun-0]|TX|7801/4;2061/4;1579/4;1332/4;1010/4;686/4;460/4|
00000000|MMI|23.71|Renal Artery Stenosis|C0035067|[dsyn]|["RENAL ARTERY STENOSIS"-tx-22-"renal artery stenosis"-noun-0]|TX|[3160/21],[3196/21]|C12.777.419.775;C13.351.968.419.775;C14.907.137.727
00000000|MMI|23.56|Levoxyl|C0721346|[aapp,phsu]|["Levoxyl"-tx-27-"levoxyl"-noun-0,"Levoxyl"-tx-7-"LEVOXYL"-noun-0]|TX|4308/7;882/7|D06.472.931.812;D12.125.072.050.767
00000000|MMI|23.53|Levothyroxine Sodium|C0079691|[aapp,horm,phsu]|["Laevothyroxine sodium"-tx-10-"LEVOTHYROXINE SODIUM"-noun-0,"Laevothyroxine sodium"-tx-7-"LEVOTHYROXINE SODIUM"-noun-0]|TX|1052/20;892/20|D06.472.931.812;D12.125.072.050.767
00000000|MMI|23.30|Food-Drug Interactions|C0242785|[dsyn]|["Interaction, Food-Drug"-tx-16-"Food/Drug Interaction"-noun-0,"Interaction, Food-Drug"-tx-10-"Food/Drug Interaction"-noun-0]|TX|1794/21;1173/21|G07.690.773.968.511
00000000|MMI|23.26|Glipizide|C0017642|[orch,phsu]|["GLIPIZIDE"-tx-27-"glipizide"-noun-0,"GLIPIZIDE"-tx-21-"GLIPIZIDE"-noun-0]|TX|4355/9;2212/9|D02.886.590.795.500
00000000|MMI|23.25|Treatment Protocols|C0040808|[topp]|["Regimen"-tx-51-"regimen"-noun-0,"Regimen"-tx-37-"regimen"-noun-0]|TX|7446/7;6106/7|E02.183;N05.715.360.775.225
00000000|MMI|23.23|Fluorides|C0016327|[inch,phsu]|["F-"-tx-52-"f"-noun-0,"F-"-tx-51-"f"-noun-0]|TX|7638/1;7548/1|D01.248.497.158.380;D01.303.350.300
00000000|MMI|21.95|Citrus paradisi|C0947567|[plnt]|["grapefruit"-tx-10-"grapefruit"-noun-0]|TX|1213/10|B01.650.940.800.575.100.875.177.538
00000000|MMI|21.64|Diet therapy|C0012159|[hlca]|["Diet"-tx-21-"DIET"-noun-0]|TX|[2234/4],[2258/4],[2325/4]|E02.642.249
00000000|MMI|21.55|Edema|C0013604|[fndg]|["OEDEMA"-tx-29-"edema"-noun-0,"OEDEMA"-tx-27-"edema"-noun-1,"OEDEMA"-tx-22-"edema"-noun-0]|TX|5050/5;4535/5;3241/5|C23.888.277
00000000|MMI|20.70|ras Oncogene|C0034678|[gngm]|["RAS"-tx-26-"RAS"-noun-0]|TX|4067/3|G05.360.340.024.340.375.500.791.550
00000000|MMI|19.38|Generic Drugs|C0085155|[phsu]|["Generic"-tx-33-"Generic"-adj-0]|TX|[5571/7],[5626/7],[5684/7],[5717/7]|D26.360
00000000|MMI|19.12|Body Fluid Discharge|C0012621|[bdsu]|["Discharge"-tx-55-"DISCHARGE"-noun-0,"Discharge"-tx-51-"DISCHARGE"-noun-0,"Discharge"-tx-38-"discharge"-noun-0,"Discharge"-tx-36-"discharge"-noun-0,"Discharge"-tx-22-"DISCHARGE"-noun-0,"Discharge"-tx-2-"DISCHARGE"-verb-0,"Discharge"-tx-1-"DISCHARGE"-noun-0]|TX|7850/9;7383/9;6182/9;6080/9;2612/9;331/9;39/9|
00000000|MMI|19.12|Discharge, body substance|C2926602|[bdsu]|["Discharge"-tx-55-"DISCHARGE"-noun-0,"Discharge"-tx-51-"DISCHARGE"-noun-0,"Discharge"-tx-38-"discharge"-noun-0,"Discharge"-tx-36-"discharge"-noun-0,"Discharge"-tx-22-"DISCHARGE"-noun-0,"Discharge"-tx-2-"DISCHARGE"-verb-0,"Discharge"-tx-1-"DISCHARGE"-noun-0]|TX|7850/9;7383/9;6182/9;6080/9;2612/9;331/9;39/9|
00000000|MMI|19.06|Discipline of Heart Surgery|C0524727|[bmod]|["Cardiac surgery"-tx-52-"cardiac surgery"-noun-0,"Cardiac surgery"-tx-51-"cardiac surgery"-noun-0,"Cardiac surgery"-tx-47-"cardiac surgery"-noun-0,"Cardiac surgery"-tx-46-"cardiac surgery"-noun-0,"Cardiac surgery"-tx-40-"Cardiac Surgery"-noun-0,"Cardiac surgery"-tx-39-"cardiac surgery"-noun-0]|TX|[7573/15],[7723/15];7530/15;7199/15;7089/15;6453/15;6213/15|
00000000|MMI|18.90|4-azido-7-phenylpyrazolo-(1,5a)-1,3,5-triazine|C0245203|[bacs,orch]|["APPT"-tx-22-"appt"-noun-0,"APPT"-tx-21-"appt"-noun-0]|TX|2546/4;2460/4|x.x.x.x
00000000|MMI|18.88|Dilatation and Curettage|C0012358|[topp]|["D & C"-tx-51-"d/c"-noun-0,"D & C"-tx-1-"D/C"-noun-0]|TX|7425/3;194/3|E04.157.310;E04.950.300.299
00000000|MMI|18.86|Diuresis|C0012797|[ortf]|["Diuresis"-tx-36-"diuresis"-noun-0,"Diuresis"-tx-35-"diuresis"-noun-0]|TX|5990/8;5951/8|G08.852.796.241
00000000|MMI|18.82|Allopurinol|C0002144|[orch,phsu]|["ALLOPURINOL"-tx-27-"allopurinol"-noun-0,"ALLOPURINOL"-tx-5-"ALLOPURINOL"-noun-0]|TX|4325/11;502/11|D03.438.759.160
00000000|MMI|18.80|Diurese|C0719972|[orch,phsu]|["Diurese"-tx-42-"diuresing"-verb-0]|TX|6752/9|D02.886.590.700.135.261.476.716;D02.886.655.500.261.476.716;D03.438.174.261.476.716
00000000|MMI|18.74|Evaluation|C0220825|[hlca]|["Evaluation"-tx-39-"evaluation"-noun-0,"Evaluation"-tx-1-"evaluation"-noun-0]|TX|6276/10;178/10|E05.337;N05.715.360.335
00000000|MMI|18.67|Delayed Release Dosage Form|C1707664|[bodm]|["DR"-tx-51-"Dr"-noun-0,"DR"-tx-49-"Dr"-noun-0,"DR"-tx-47-"Dr"-noun-0,"DR"-tx-43-"Dr"-noun-0,"DR"-tx-39-"Dr"-noun-0,"DR"-tx-21-"DR"-noun-0,"DR"-tx-21-"Dr"-noun-0]|TX|7557/2;7311/2;7239/2;6838/2;6436/2;2412/2;2490/2|
00000000|MMI|18.67|Device to Subject Relationship Domain|C3540849|[inpr]|["DR"-tx-51-"Dr"-noun-0,"DR"-tx-49-"Dr"-noun-0,"DR"-tx-47-"Dr"-noun-0,"DR"-tx-43-"Dr"-noun-0,"DR"-tx-39-"Dr"-noun-0,"DR"-tx-21-"DR"-noun-0,"DR"-tx-21-"Dr"-noun-0]|TX|7557/2;7311/2;7239/2;6838/2;6436/2;2412/2;2490/2|
00000000|MMI|18.67|Doctor - Title|C2348314|[cnce]|["Dr."-tx-51-"Dr"-noun-0,"Dr."-tx-49-"Dr"-noun-0,"Dr."-tx-47-"Dr"-noun-0,"Dr."-tx-43-"Dr"-noun-0,"Dr."-tx-39-"Dr"-noun-0,"Dr."-tx-21-"DR"-noun-0,"Dr."-tx-21-"Dr"-noun-0]|TX|7557/2;7311/2;7239/2;6838/2;6436/2;2412/2;2490/2|
00000000|MMI|18.55|Non-Small Cell Lung Carcinoma|C0007131|[neop]|["NSCLC"-tx-26-"NSCLC"-noun-0]|TX|4149/5|C04.588.894.797.520.109.220.249;C08.381.540.140.500;C08.785.520.100.220.500
00000000|MMI|18.53|Pediculus (eukaryote)|C0030760|[euka]|["Nit"-tx-29-"nit"-noun-0]|TX|4887/3|B01.050.500.131.617.690.060.716
00000000|MMI|18.46|Daunorubicin|C0011015|[antb,orch]|["DNR"-tx-47-"DNR"-noun-0]|TX|7135/3|D02.455.426.559.847.562.050.200;D04.615.562.050.200;D09.408.051.059.200
00000000|MMI|17.39|Hydroxymethylglutaryl-CoA Reductase Inhibitors|C0360714|[orch,phsu]|["Statin"-tx-32-"statin"-noun-0]|TX|5410/6|D27.505.519.186.071.202.370;D27.505.519.389.370;D27.505.954.557.500.202.370
00000000|MMI|17.39|Pravastatin|C0085542|[orch,phsu]|["PRAVASTATIN"-tx-10-"PRAVASTATIN"-noun-0]|TX|1142/11|D02.455.426.559.847.638.930;D04.615.638.930
00000000|MMI|16.63|Hypothyroidism|C0020676|[dsyn]|["HYPOTHYROIDISM"-tx-22-"hypothyroidism"-noun-0]|TX|[2938/14],[2955/14]|C19.874.482
00000000|MMI|16.46|Order (action)|C1705178|[acty]|["Order"-tx-55-"ORDERS"-verb-0,"Order"-tx-16-"order"-noun-0,"Order"-tx-13-"order"-noun-0,"Order"-tx-7-"order"-noun-0,"Order"-tx-1-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|7860/6;1588/5;1341/5;695/5;198/5;49/6|
00000000|MMI|16.46|Order (arrangement)|C1705176|[qlco]|["Order"-tx-55-"ORDERS"-verb-0,"Order"-tx-16-"order"-noun-0,"Order"-tx-13-"order"-noun-0,"Order"-tx-7-"order"-noun-0,"Order"-tx-1-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|7860/6;1588/5;1341/5;695/5;198/5;49/6|
00000000|MMI|16.46|Order (document)|C1705175|[inpr]|["Order"-tx-55-"ORDERS"-verb-0,"Order"-tx-16-"order"-noun-0,"Order"-tx-13-"order"-noun-0,"Order"-tx-7-"order"-noun-0,"Order"-tx-1-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|7860/6;1588/5;1341/5;695/5;198/5;49/6|
00000000|MMI|16.46|Order (taxonomic)|C1705177|[clas]|["Order"-tx-55-"ORDERS"-verb-0,"Order"-tx-16-"order"-noun-0,"Order"-tx-13-"order"-noun-0,"Order"-tx-7-"order"-noun-0,"Order"-tx-1-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|7860/6;1588/5;1341/5;695/5;198/5;49/6|
00000000|MMI|16.46|Permutation|C1882348|[qlco]|["Order"-tx-55-"ORDERS"-verb-0,"Order"-tx-16-"order"-noun-0,"Order"-tx-13-"order"-noun-0,"Order"-tx-7-"order"-noun-0,"Order"-tx-1-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|7860/6;1588/5;1341/5;695/5;198/5;49/6|
00000000|MMI|16.46|Sequence of Planned Assessment Schedule|C3889825|[inpr]|["ORDER"-tx-55-"ORDERS"-verb-0,"ORDER"-tx-16-"order"-noun-0,"ORDER"-tx-13-"order"-noun-0,"ORDER"-tx-7-"order"-noun-0,"ORDER"-tx-1-"ORDER"-noun-0,"ORDER"-tx-1-"ORDERS"-verb-0]|TX|7860/6;1588/5;1341/5;695/5;198/5;49/6|
00000000|MMI|16.38|Interaction|C1704675|[ftcn]|["Interaction"-tx-20-"INTERACTION"-noun-0,"Interaction"-tx-16-"INTERACTION"-noun-0,"Interaction"-tx-13-"INTERACTION"-noun-0,"Interaction"-tx-10-"INTERACTION"-noun-0,"Interaction"-tx-7-"INTERACTION"-noun-0,"Interaction"-tx-5-"INTERACTION"-noun-0]|TX|2087/11;1650/11;1402/11;1024/11;757/11;474/11|
00000000|MMI|16.29|Receptors, Complement 3d|C0056184|[aapp,imft,rcpt]|["CR2"-tx-26-"Cr 2"-noun-0]|TX|4131/4|D12.776.543.750.705.833.610;D12.776.543.750.925.250;D23.050.301.264.035.610;D23.101.100.110.610
00000000|MMI|16.16|therapeutic aspects|C0039798|[ftcn]|["treatment"-tx-22-"Treatment"-noun-0]|TX|2771/9|x.x.x.x.x.x.x
00000000|MMI|16.07|Indication of (contextual qualifier)|C0392360|[idcn]|["Reason"-tx-21-"Reason"-noun-0,"Reason"-tx-16-"Reason"-noun-0,"Reason"-tx-14-"Reason"-noun-0,"Reason"-tx-10-"Reason"-noun-0,"Reason"-tx-7-"Reason"-noun-0,"Reason"-tx-5-"Reason"-noun-0]|TX|2143/6;1697/6;1458/6;1073/6;793/6;514/6|
00000000|MMI|15.98|Additional|C1524062|[ftcn]|["Added"-tx-17-"added"-verb-0,"Added"-tx-14-"added"-verb-0,"Added"-tx-11-"added"-verb-0,"Added"-tx-7-"added"-verb-0,"Added"-tx-5-"added"-verb-0,"Added"-tx-2-"added"-verb-0]|TX|2010/5;1528/5;1281/5;959/5;635/5;409/5|
00000000|MMI|15.65|Serious|C0205404|[qlco]|["Serious"-tx-20-"SERIOUS"-adj-0,"Serious"-tx-16-"SERIOUS"-adj-0,"Serious"-tx-13-"SERIOUS"-adj-0,"Serious"-tx-10-"SERIOUS"-adj-0,"Serious"-tx-7-"SERIOUS"-adj-0,"Serious"-tx-5-"SERIOUS"-adj-0]|TX|2079/7;1642/7;1394/7;1016/7;749/7;466/7|
00000000|MMI|15.61|/40|C0439509|[tmco]|["/40"-tx-34-"40"-percentage-0,"/40"-tx-33-"40"-percentage-0,"/40"-tx-29-"40"-percentage-0,"/40"-tx-28-"40"-percentage-0,"/40"-tx-27-"40"-integer-0,"/40"-tx-10-"40"-integer-0]|TX|5824/2;5692/2;4735/2;4585/2;4222/2;1156/2|
00000000|MMI|15.61|40%|C3842587|[qnco]|["40%"-tx-34-"40"-percentage-0,"40%"-tx-33-"40"-percentage-0,"40%"-tx-29-"40"-percentage-0,"40%"-tx-28-"40"-percentage-0,"40%"-tx-27-"40"-integer-0,"40%"-tx-10-"40"-integer-0]|TX|5824/2;5692/2;4735/2;4585/2;4222/2;1156/2|
00000000|MMI|15.12|Esomeprazole|C0937846|[orch,phsu]|["ESOMEPRAZOLE"-tx-21-"ESOMEPRAZOLE"-noun-0]|TX|2182/12|D02.886.640.074.500.500;D03.383.725.024.500.500;D03.438.103.034.500.500
00000000|MMI|15.12|Furosemide|C0016860|[orch,phsu]|["FUROSEMIDE"-tx-7-"FUROSEMIDE"-noun-0]|TX|831/10|D02.065.884.725.300;D02.092.146.807.300;D02.886.590.700.725.300
00000000|MMI|15.12|Vision|C0042789|[orgf]|["see"-tx-41-"see"-verb-0]|TX|6589/3|F02.830.816.964;G02.111.087.800.480.900;G02.149.115.800.480.900;G04.299.880.480.900;G11.561.600.810.964;G14.640.816
00000000|MMI|14.61|Disease|C0012634|[dsyn]|["condition"-tx-51-"CONDITION"-noun-0,"condition"-tx-22-"Conditions"-noun-0]|TX|7393/9;2719/10|C23.550.288
00000000|MMI|14.56|Dental Health Services|C0011365|[hlca]|["Dental"-tx-52-"dental"-adj-0,"Dental"-tx-39-"dental"-adj-0]|TX|7667/6;6351/6|N02.421.240
00000000|MMI|14.04|Toprol-XL|C0723783|[orch,phsu]|["Toprol XL"-tx-16-"TOPROL XL"-noun-0]|TX|1727/9|D02.033.100.624.698.573;D02.033.755.624.698.573;D02.092.063.624.698.573
00000000|MMI|13.97|Meal (occasion for eating)|C1998602|[dora]|["Meals"-tx-16-"meals"-noun-0]|TX|1851/5|F01.145.407.432.500;F01.145.466.349.500;G07.203.300.590;G07.203.650.353.432.500;J02.500.590
00000000|MMI|13.97|Alaska|C0001905|[geoa]|["AK"-tx-28-"AK"-noun-0]|TX|4618/2|Z01.107.567.875.580.100
00000000|MMI|13.88|Metoprolol|C0025859|[orch,phsu]|["METOPROLOL"-tx-27-"metoprolol"-noun-0]|TX|4283/10|D02.033.100.624.698.573;D02.033.755.624.698.573;D02.092.063.624.698.573
00000000|MMI|13.87|Nicotinamide adenine dinucleotide (NAD)|C0027270|[bacs,nnon,phsu]|["NAD+"-tx-27-"NAD"-noun-0]|TX|4459/3|D03.438.759.646.138.694;D08.211.589;D13.695.667.138.694;D13.695.827.068.694
00000000|MMI|13.85|Jaw|C0022359|[bpoc]|["Jaw"-tx-25-"jaw"-noun-0]|TX|3946/3|A02.835.232.781.324.502;A14.521
00000000|MMI|13.47|Congestive heart failure|C0018802|[dsyn]|["CHF"-tx-29-"CHF"-noun-0,"CHF"-tx-22-"CHF"-noun-0,"CONGESTIVE HEART FAILURE"-tx-22-"congestive heart failure"-noun-0]|TX|5219/3;[2786/3],[3385/3],[3528/3];2792/24|
00000000|MMI|13.41|+2|C0740116|[qnco]|["+2"-tx-46-"2"-real_number-0,"+2"-tx-42-"2"-integer-0,"+2"-tx-29-"2"-integer-0,"+2"-tx-22-"2"-integer-0,"+2"-tx-21-"2"-integer-0]|TX|7020/1;6666/1;4873/1;2995/1;2331/1|
00000000|MMI|13.41|2+|C3833492|[fndg]|["2+"-tx-46-"2"-real_number-0,"2+"-tx-42-"2"-integer-0,"2+"-tx-29-"2"-integer-0,"2+"-tx-22-"2"-integer-0,"2+"-tx-21-"2"-integer-0]|TX|7020/1;6666/1;4873/1;2995/1;2331/1|
00000000|MMI|13.41|2+ Score|C2827735|[qnco]|["2+"-tx-46-"2"-real_number-0,"2+"-tx-42-"2"-integer-0,"2+"-tx-29-"2"-integer-0,"2+"-tx-22-"2"-integer-0,"2+"-tx-21-"2"-integer-0]|TX|7020/1;6666/1;4873/1;2995/1;2331/1|
00000000|MMI|13.41|2+ Score, WHO|C2981700|[clas]|["2+"-tx-46-"2"-real_number-0,"2+"-tx-42-"2"-integer-0,"2+"-tx-29-"2"-integer-0,"2+"-tx-22-"2"-integer-0,"2+"-tx-21-"2"-integer-0]|TX|7020/1;6666/1;4873/1;2995/1;2331/1|
00000000|MMI|12.92|80%|C3842583|[fndg]|["80%"-tx-37-"80"-integer-0,"80%"-tx-36-"80"-integer-0,"80%"-tx-34-"80"-percentage-0,"80%"-tx-33-"80"-percentage-0,"80%"-tx-7-"80"-integer-0]|TX|6147/2;6030/2;5816/2;5634/2;844/2|
00000000|MMI|12.90|Home environment|C0442519|[cnce]|["HOME"-tx-51-"home"-noun-0,"HOME"-tx-41-"home"-noun-0,"HOME"-tx-39-"home"-noun-0,"house"-tx-21-"House"-noun-0]|TX|7432/4;6522/4;6395/4;[2264/5],[2300/5]|
00000000|MMI|12.89|Lesion|C0221198|[fndg]|["Lesion"-tx-33-"lesion"-noun-0,"Lesion"-tx-33-"lesion"-noun-1,"lesions"-tx-33-"lesions"-noun-1]|TX|[5583/6],[5638/6],[5696/6],[5729/6];[5583/6],[5638/6],[5696/6],[5729/6];5501/7|
00000000|MMI|12.84|Barbados|C0004739|[geoa]|["BB"-tx-32-"BB"-noun-0]|TX|5405/2|Z01.107.084.900.140;Z01.639.880.140
00000000|MMI|12.84|Basal cell carcinoma|C0007117|[neop]|["BASAL CELL CARCINOMA"-tx-22-"basal cell carcinoma"-noun-0]|TX|3103/20|C04.557.470.200.165;C04.557.470.565.165
00000000|MMI|12.84|Coronary Arteriosclerosis|C0010054|[dsyn]|["coronary artery disease"-tx-22-"coronary artery disease"-noun-0]|TX|2825/23|C14.280.647.250.260;C14.907.137.126.339;C14.907.585.250.260
00000000|MMI|12.84|Coronary Artery Disease|C1956346|[dsyn]|["CORONARY ARTERY DISEASE"-tx-22-"coronary artery disease"-noun-0]|TX|2825/23|C14.280.647.250.260;C14.907.137.126.339;C14.907.585.250.260
00000000|MMI|12.84|Postoperative Period|C0032790|[tmco]|["Postop"-tx-29-"postop"-adj-0]|TX|5058/6|E04.614.750;N02.421.585.753.750
00000000|MMI|12.84|Specificity|C0037791|[qnco]|["Specificity"-tx-31-"specificity"-noun-0]|TX|5386/11|E05.318.740.872;E05.318.780.800;G17.800;N05.715.360.750.725;N05.715.360.780.700;N06.850.520.445.800;N06.850.520.830.872
00000000|MMI|12.79|Magnesium Cation|C2346927|[elii,phsu]|["Mg++"-tx-27-"mg"-noun-0,"Mg++"-tx-16-"MG"-noun-0,"Mg++"-tx-10-"MG"-noun-0,"Mg++"-tx-7-"MG"-noun-0,"Mg++"-tx-5-"MG"-noun-0]|TX|4373/2;1782/2;1159/2;847/2;597/2|
00000000|MMI|12.79|Milligram percent|C1960952|[qnco]|["mg %"-tx-27-"mg"-noun-0,"mg %"-tx-16-"MG"-noun-0,"mg %"-tx-10-"MG"-noun-0,"mg %"-tx-7-"MG"-noun-0,"mg %"-tx-5-"MG"-noun-0]|TX|4373/2;1782/2;1159/2;847/2;597/2|
00000000|MMI|12.79|mg/dL|C0439269|[qnco]|["mg%"-tx-27-"mg"-noun-0,"mg%"-tx-16-"MG"-noun-0,"mg%"-tx-10-"MG"-noun-0,"mg%"-tx-7-"MG"-noun-0,"mg%"-tx-5-"MG"-noun-0]|TX|4373/2;1782/2;1159/2;847/2;597/2|
00000000|MMI|12.76|50%|C3842586|[fndg]|["50%"-tx-34-"50"-percentage-0,"50%"-tx-33-"50"-percentage-0,"50%"-tx-33-"50"-percentage-1,"50%"-tx-16-"50"-integer-0]|TX|[5765/2],[5857/2];[5579/2],[5725/2];[5579/2],[5725/2];1779/2|
00000000|MMI|12.76|<50|C3843766|[fndg]|["<50"-tx-34-"50"-percentage-0,"<50"-tx-33-"50"-percentage-0,"<50"-tx-33-"50"-percentage-1,"<50"-tx-16-"50"-integer-0]|TX|[5765/2],[5857/2];[5579/2],[5725/2];[5579/2],[5725/2];1779/2|
00000000|MMI|11.81|Renal Insufficiency|C1565489|[dsyn]|["Renal dysfunction"-tx-22-"renal dysfunction"-noun-0]|TX|3140/17|C12.777.419.780;C13.351.968.419.780
00000000|MMI|11.79|Fat-Restricted Diet|C0242970|[topp]|["Low fat diet, NOS"-tx-21-"Low fat DIET"-noun-0]|TX|2272/3,2290/8|E02.642.249.260;G07.203.650.240.260
00000000|MMI|11.76|Coronary Artery Bypass Surgery|C0010055|[topp]|["CABG"-tx-39-"CABG"-noun-0]|TX|6241/4|E04.100.376.719.332;E04.100.814.868.750;E04.928.220.520.220
00000000|MMI|11.76|Left Bundle-Branch Block|C0023211|[dsyn]|["LBBB"-tx-29-"LBBB"-noun-0]|TX|4942/4|C14.280.067.558.323;C23.550.073.425.100
00000000|MMI|11.76|Saint Lucia|C0036056|[geoa]|["ST"-tx-31-"ST"-noun-0]|TX|5338/2|Z01.107.084.900.825;Z01.639.880.825
00000000|MMI|11.72|Hong Kong|C0019907|[geoa]|["HK"-tx-28-"HK"-noun-0]|TX|4639/2|Z01.252.474.164.450
00000000|MMI|11.70|Adenosine|C0001443|[bacs,nnon,phsu]|["ADENOSINE"-tx-29-"adenosine"-noun-0]|TX|4773/9|D03.438.759.590.138;D13.570.583.138;D13.570.800.096;x.x.x.x
00000000|MMI|11.70|Urinalysis|C0042014|[lbpr]|["UA"-tx-29-"UA"-noun-0]|TX|4869/2|E01.370.225.124.810;E01.370.390.810;E05.200.124.810
00000000|MMI|11.70|Films as Topic|C4019020|[inpr]|["Films"-tx-39-"films"-noun-0]|TX|6358/5|J01.897.280.500.598;L01.178.590.500;L01.178.820.090.598
00000000|MMI|11.70|Electrocardiogram|C0013798|[fndg]|["EKG"-tx-29-"EKG"-noun-0]|TX|4898/3|E01.370.370.380.240;E01.370.405.240
00000000|MMI|11.70|Electrocardiography|C1623258|[diap]|["EKG"-tx-29-"EKG"-noun-0]|TX|4898/3|E01.370.370.380.240;E01.370.405.240
00000000|MMI|11.70|Lebanon|C0023190|[geoa]|["LE"-tx-29-"le"-noun-0]|TX|4891/2|Z01.252.245.500.450
00000000|MMI|11.68|Somalia|C0037640|[geoa]|["SO"-tx-41-"so"-adv-0]|TX|6538/2|Z01.058.290.120.730
00000000|MMI|11.62|Heart Septal Defects|C0018816|[cgab,dsyn]|["Septal defect"-tx-29-"septal defect"-noun-0]|TX|4855/13|C14.240.400.560;C14.280.400.560;C16.131.240.400.560
00000000|MMI|11.61|Creatinine|C0010294|[bacs,orch]|["CREATININE"-tx-42-"creatinine"-noun-0]|TX|6731/10|D03.383.129.308.207
00000000|MMI|11.60|InFed|C0721062|[orch,phsu]|["inf"-tx-29-"inf"-noun-0]|TX|4851/3|D02.691.550.100.500;D09.698.365.272.400
00000000|MMI|11.60|Sodium Chloride|C0037494|[bacs,inch,phsu]|["Salt"-tx-45-"salt"-noun-0]|TX|6880/4|D01.210.450.150.875;D01.857.650
00000000|MMI|11.59|British Virgin Islands|C0205999|[geoa]|["VI"-tx-27-"vi"-noun-0]|TX|4495/2|Z01.107.084.900.182
00000000|MMI|11.58|Lesotho|C0023376|[geoa]|["LT"-tx-46-"lt"-noun-0]|TX|7017/2|Z01.058.290.175.400
00000000|MMI|11.31|To|C1883351|[qlco]|["To"-tx-48-"to"-adv-0,"To"-tx-41-"to"-adv-0,"To"-tx-21-"to"-adv-0]|TX|7279/2;6586/2;2452/2|
00000000|MMI|11.08|Hospital admission|C0184666|[hlca]|["admitted"-tx-24-"admitted"-verb-0,"Admission"-tx-23-"admission"-noun-0,"Admission"-tx-22-"Admission"-noun-0,"Admit"-tx-22-"ADMIT"-verb-0]|TX|3800/8;3681/9;2669/9;2569/5|
00000000|MMI|10.67|Changed status|C0443172|[qnco]|["Changed"-tx-51-"changed"-verb-0,"change"-tx-37-"change"-noun-0,"changes"-tx-31-"changes"-verb-0,"changes"-tx-29-"changes"-verb-0]|TX|7473/7;6096/6;5341/7;5065/7|
00000000|MMI|10.67|Changing|C0392747|[ftcn]|["Changed"-tx-51-"changed"-verb-0,"Change"-tx-37-"change"-noun-0,"changes"-tx-31-"changes"-verb-0,"changes"-tx-29-"changes"-verb-0]|TX|7473/7;6096/6;5341/7;5065/7|
00000000|MMI|10.57|ACE protein, human|C1452534|[aapp,bacs]|["ACE"-tx-32-"ACE"-noun-0]|TX|5419/3|x.x.x.x
00000000|MMI|10.57|Coronary heart disease|C0010068|[dsyn]|["Coronary (artery) disease"-tx-22-"coronary artery disease"-noun-0]|TX|2825/23|C14.280.647.250;C14.907.585.250
00000000|MMI|10.57|Diabetes Mellitus|C0011849|[dsyn]|["DIABETES MELLITUS"-tx-22-"diabetes mellitus"-noun-0]|TX|2877/17|C18.452.394.750;C19.246
00000000|MMI|10.57|Ethanol|C0001962|[orch,phsu]|["ETOH"-tx-27-"EtOH"-noun-0]|TX|4410/4|D02.033.375;x.x.x.x
00000000|MMI|10.57|Lead|C0023175|[elii,hops]|["???lead"-tx-31-"leads"-verb-0]|TX|5373/5|D01.268.556.435;D01.552.544.435;x.x.x.x
00000000|MMI|10.57|Mitral Valve Insufficiency|C0026266|[patf]|["MITRAL REGURGITATION"-tx-22-"mitral regurgitation"-noun-0]|TX|2972/20|C14.280.484.461
00000000|MMI|10.57|Nicotinic Acids|C0028049|[orch,phsu,vita]|["nicotinic acid"-tx-17-"NICOTINIC ACID"-noun-0]|TX|1932/14|D03.066.515;D03.383.725.547
00000000|MMI|10.57|Set (Psychology)|C0036849|[menp]|["Set"-tx-30-"sets"-verb-0]|TX|5276/4|F02.463.425.838
00000000|MMI|10.57|MRC1 gene|C1417249|[gngm]|["MR"-tx-29-"MR"-noun-0,"MR"-tx-28-"MR"-noun-0,"MR"-tx-26-"MR"-noun-0,"MR"-tx-22-"MR"-noun-0]|TX|5153/2;4674/2;4018/2;3472/2|
00000000|MMI|10.57|Minor Response|C4050513|[fndg]|["MR"-tx-29-"MR"-noun-0,"MR"-tx-28-"MR"-noun-0,"MR"-tx-26-"MR"-noun-0,"MR"-tx-22-"MR"-noun-0]|TX|5153/2;4674/2;4018/2;3472/2|
00000000|MMI|10.57|Mr. - Title|C2347167|[cnce]|["Mr."-tx-29-"MR"-noun-0,"Mr."-tx-28-"MR"-noun-0,"Mr."-tx-26-"MR"-noun-0,"Mr."-tx-22-"MR"-noun-0]|TX|5153/2;4674/2;4018/2;3472/2|
00000000|MMI|10.54|Baseline|C1442488|[qnco]|["Baseline"-tx-42-"baseline"-noun-0,"Baseline"-tx-31-"Baseline"-noun-0,"Baseline"-tx-26-"baseline"-noun-0,"Baseline"-tx-25-"baseline"-noun-0]|TX|6707/8;5329/8;4122/8;3838/8|
00000000|MMI|10.41|CALD1 wt Allele|C3813548|[gngm]|["CAD"-tx-33-"CAD"-noun-0,"CAD"-tx-26-"CAD"-adj-0,"CAD"-tx-22-"CAD"-adj-0,"CAD"-tx-22-"cad"-noun-0]|TX|5758/3;3967/3;3410/3;2819/3|
00000000|MMI|10.34|100%|C3817553|[qnco]|["100%"-tx-29-"100"-percentage-0,"100%"-tx-27-"100"-integer-0,"100%"-tx-27-"100"-percentage-0,"100%"-tx-7-"100"-integer-0]|TX|4726/3;[4337/3],[4447/3];[4337/3],[4447/3];915/3|
00000000|MMI|10.34|Recurrent|C2945760|[tmco]|["RECURRENT"-tx-29-"recurrent"-adj-0,"RECURRENT"-tx-26-"recurrent"-adj-0,"RECURRENT"-tx-22-"recurrent"-adj-0]|TX|5158/9;4168/9;[3220/9],[3538/9]|
00000000|MMI|10.13|Specimen Source Codes - Lesion|C1546698|[inpr]|["Lesion"-tx-33-"lesion"-noun-0]|TX|[5583/6],[5638/6],[5696/6],[5729/6]|
00000000|MMI|10.13|Borg Category-Ratio 10 Perceived Exertion Score 5|C4050466|[inpr]|["Severe"-tx-33-"severe"-adj-0,"Severe"-tx-28-"severe"-adj-0,"Severe"-tx-26-"severe"-adj-0,"Severe"-tx-22-"severe"-adj-0]|TX|5751/6;4659/6;4011/6;3465/6|
00000000|MMI|10.13|Severe (severity modifier)|C0205082|[qlco]|["SEVERE"-tx-33-"severe"-adj-0,"SEVERE"-tx-28-"severe"-adj-0,"SEVERE"-tx-26-"severe"-adj-0,"SEVERE"-tx-22-"severe"-adj-0]|TX|5751/6;4659/6;4011/6;3465/6|
00000000|MMI|10.13|Severe Extremity Pain|C4050465|[inpr]|["Severe"-tx-33-"severe"-adj-0,"Severe"-tx-28-"severe"-adj-0,"Severe"-tx-26-"severe"-adj-0,"Severe"-tx-22-"severe"-adj-0]|TX|5751/6;4659/6;4011/6;3465/6|
00000000|MMI|9.76|Educational process of instructing|C0039401|[edac]|["Instruction"-tx-16-"Instruction"-noun-0,"Instruction"-tx-10-"Instruction"-noun-0]|TX|1816/11;1195/11|I02.903
00000000|MMI|9.56|Home visit (procedure)|C0020043|[hlca]|["home services"-tx-2-"Home services"-noun-0]|TX|314/4,322/8|N04.452.758.307
00000000|MMI|9.44|Infantile Neuroaxonal Dystrophy|C0270724|[dsyn]|["PLAN"-tx-51-"PLAN"-noun-0]|TX|7417/4|C10.228.140.744
00000000|MMI|9.43|Ukraine|C0041580|[geoa]|["UA"-tx-29-"UA"-noun-0]|TX|4869/2|Z01.542.248.960;Z01.586.200.960;Z01.586.950.960
00000000|MMI|9.42|Christmas Island|C0006888|[geoa]|["CXR"-tx-29-"CXR"-noun-0]|TX|5017/3|Z01.639.100;Z01.678.100.373
00000000|MMI|9.42|Leukocytes|C0023516|[cell]|["WBC"-tx-29-"wbc"-noun-0]|TX|4894/3|A11.118.637;A15.145.229.637;A15.382.490
00000000|MMI|9.42|Uterus|C0042149|[bpoc]|["Uterine"-tx-26-"uterine"-adj-0]|TX|4082/7|A05.360.319.679
00000000|MMI|9.40|Rabbi|C0684010|[prog]|["R."-tx-22-"R"-noun-0]|TX|3338/1|M01.526.799.500
00000000|MMI|9.40|Self|C0036588|[idcn]|["Self"-tx-41-"self"-noun-0]|TX|6547/4|F01.752.747.189;F02.739.794.206
00000000|MMI|9.40|Stomach|C0038351|[bpoc]|["STOMACH"-tx-16-"stomach"-noun-0]|TX|1869/7|A03.556.875.875
00000000|MMI|9.39|General surgery specialty|C1274039|[bmod]|["Surgery"-tx-39-"surgery"-noun-0]|TX|6261/7|H02.403.810.300
00000000|MMI|9.35|Oxygen|C0030054|[elii,phsu]|["O2"-tx-42-"O2"-noun-0]|TX|6679/2|D01.268.185.550;D01.362.670;x.x.x.x
00000000|MMI|9.34|Aggressive behavior|C0001807|[mobd]|["aggressive"-tx-46-"Aggressive"-adj-0]|TX|6904/10|F01.145.126.125;F01.145.813.045
00000000|MMI|9.34|Paraguay|C0030428|[geoa]|["PA"-tx-28-"PA"-noun-0]|TX|4690/2|Z01.107.757.656
00000000|MMI|9.33|1-(2-(dodecyloxy)ethyl)pyrrolidine hydrochloride|C0057472|[orch,phsu]|["DEP"-tx-29-"dep"-noun-0]|TX|4995/3|x.x.x.x
00000000|MMI|9.33|Sodium|C0037473|[bacs,elii]|["SODIUM"-tx-21-"Sodium"-noun-0]|TX|2338/6|D01.268.549.750;D01.268.557.650;D01.552.528.850;D01.552.547.725;x.x.x.x
00000000|MMI|9.32|Sodium Chloride, Dietary|C0206136|[food]|["Salt"-tx-45-"salt"-noun-0]|TX|6880/4|D01.857.650.705;D01.857.700.705
00000000|MMI|9.32|Gentamicin Sulfate (USP)|C0546866|[antb,orch]|["GM"-tx-17-"GM"-noun-0]|TX|1971/2|D09.408.051.374
00000000|MMI|9.32|ECHO protocol|C0058928|[topp]|["ECHO"-tx-28-"ECHO"-noun-0]|TX|4572/4|x.x.x.x
00000000|MMI|9.32|Rales|C0034642|[sosy]|["RALES"-tx-27-"rales"-noun-0]|TX|4479/5|C23.888.852.779;E01.370.386.720;G09.772.775
00000000|MMI|9.31|Automobiles|C0004381|[mnob]|["Car"-tx-1-"CAR"-noun-0]|TX|106/3|J01.937.500.100
00000000|MMI|8.37|Pharmacogenomics Trial Characteristics Domain|C3714755|[inpr]|["PT"-tx-41-"Pt"-noun-0,"PT"-tx-39-"Pt"-noun-0,"PT"-tx-39-"pt"-noun-0]|TX|6503/2;6193/2;6338/2|
00000000|MMI|8.37|Physical therapy (field)|C0699718|[bmod]|["PT"-tx-41-"Pt"-noun-0,"PT"-tx-39-"Pt"-noun-0,"PT"-tx-39-"pt"-noun-0]|TX|6503/2;6193/2;6338/2|
00000000|MMI|8.29|Allergy Specialty|C0002111|[bmod]|["Allergy"-tx-22-"ALLERGY"-noun-0]|TX|2556/7|H02.403.044
00000000|MMI|8.29|Complication Aspects|C1171258|[patf]|["complications"-tx-22-"Complications"-noun-0]|TX|2745/13|x.x.x
00000000|MMI|8.29|Ischemia|C0022116|[patf]|["Ischaemia, NOS"-tx-30-"Ischemia"-noun-0]|TX|5260/8|C23.550.513
00000000|MMI|8.29|Kidney|C0022646|[bpoc]|["Renal"-tx-42-"RENAL"-adj-0]|TX|6700/5|A05.810.453
00000000|MMI|8.29|Methods aspects|C0025664|[inpr]|["procedures"-tx-22-"PROCEDURES"-noun-0]|TX|3282/10|x.x.x
00000000|MMI|8.29|Patient Monitoring|C0030695|[hlca]|["monitor"-tx-41-"monitor"-verb-0]|TX|6530/7|E01.370.520
00000000|MMI|8.29|utilization qualifier|C0042153|[ftcn]|["use"-tx-25-"uses"-verb-0]|TX|3904/4|x.x.x
00000000|MMI|8.25|Methylcytosine Dioxygenase TET1|C2987138|[aapp,enzy]|["LCX"-tx-34-"LCX"-noun-0,"LCX"-tx-26-"LCx"-noun-0,"LCX"-tx-22-"LCx"-noun-0]|TX|5802/3;4001/3;3450/3|
00000000|MMI|8.25|TET1 gene|C1428863|[gngm]|["LCX"-tx-34-"LCX"-noun-0,"LCX"-tx-26-"LCx"-noun-0,"LCX"-tx-22-"LCx"-noun-0]|TX|5802/3;4001/3;3450/3|
00000000|MMI|8.25|TET1 wt Allele|C2987137|[gngm]|["LCX"-tx-34-"LCX"-noun-0,"LCX"-tx-26-"LCx"-noun-0,"LCX"-tx-22-"LCx"-noun-0]|TX|5802/3;4001/3;3450/3|
00000000|MMI|8.17|HP gene|C1415692|[gngm]|["Bp"-tx-41-"BP"-noun-0,"Bp"-tx-24-"BP"-noun-0]|TX|[6527/2],[6562/2];3779/2|
00000000|MMI|8.17|HP wt Allele|C1708288|[gngm]|["BP"-tx-41-"BP"-noun-0,"BP"-tx-24-"BP"-noun-0]|TX|[6527/2],[6562/2];3779/2|
00000000|MMI|8.13|Complete Response with Incomplete Bone Marrow Recovery|C3538993|[fndg]|["CRi"-tx-42-"CRI"-noun-1,"CRi"-tx-26-"CRI"-noun-0,"CRi"-tx-22-"CRI"-noun-0]|TX|6716/3;4118/3;3126/3|
00000000|MMI|8.13|Cranial Rhythmic Impulse|C1704519|[phsf]|["CRI"-tx-42-"CRI"-noun-1,"CRI"-tx-26-"CRI"-noun-0,"CRI"-tx-22-"CRI"-noun-0]|TX|6716/3;4118/3;3126/3|
00000000|MMI|8.13|RNH1 gene|C1826843|[gngm]|["CRI"-tx-42-"CRI"-noun-0,"CRI"-tx-26-"CRI"-noun-0,"CRI"-tx-22-"CRI"-noun-0]|TX|6716/3;4118/3;3126/3|
00000000|MMI|8.12|Admission activity|C0809949|[hlca]|["Admitted"-tx-24-"admitted"-verb-0,"Admission"-tx-23-"admission"-noun-0,"Admission"-tx-22-"Admission"-noun-0]|TX|3800/8;3681/9;2669/9|
00000000|MMI|8.11|Flash|C0262485|[diap]|["Flash"-tx-35-"flash"-verb-0,"Flash"-tx-22-"flash"-noun-0,"Flash"-tx-22-"flash"-verb-0]|TX|5877/5;[2681/5],[3230/5];[2681/5],[3230/5]|
00000000|MMI|8.11|Light Sources, Flash|C0181637|[medd]|["flash"-tx-35-"flash"-verb-0,"flash"-tx-22-"flash"-noun-0,"flash"-tx-22-"flash"-verb-0]|TX|5877/5;[2681/5],[3230/5];[2681/5],[3230/5]|
00000000|MMI|8.04|Requirement|C1514873|[ftcn]|["Requirement"-tx-42-"requirement"-noun-0,"Requirement"-tx-22-"requirements"-noun-0,"Required"-tx-17-"Required"-verb-0]|TX|6682/11;3605/12;1894/8|
00000000|MMI|8.03|ALYREF gene|C1425988|[gngm]|["REF"-tx-16-"ref"-noun-0,"REF"-tx-13-"ref"-noun-0,"REF"-tx-7-"ref"-noun-0]|TX|1612/3;1364/3;719/3|
00000000|MMI|8.01|Delta (difference)|C1705241|[qnco]|["Change"-tx-37-"change"-noun-0,"Change"-tx-31-"changes"-verb-0,"Change"-tx-29-"changes"-verb-0]|TX|6096/6;5341/7;5065/7|
00000000|MMI|7.87|Basal Diet|C2983588|[food]|["DIET"-tx-21-"DIET"-noun-0]|TX|[2234/4],[2258/4],[2325/4]|
00000000|MMI|7.87|Diet (animal life circumstance)|C3668949|[food]|["Diet"-tx-21-"DIET"-noun-0]|TX|[2234/4],[2258/4],[2325/4]|
00000000|MMI|7.87|Special Diet Therapy|C1519433|[topp]|["DIET"-tx-21-"DIET"-noun-0]|TX|[2234/4],[2258/4],[2325/4]|
00000000|MMI|7.85|Negation|C1518422|[ftcn]|["Non"-tx-33-"non"-adj-0,"Not"-tx-23-"not"-adv-0,"Not"-tx-22-"NOT"-adv-0]|TX|5747/3;3719/3;3329/3|
00000000|MMI|7.85|Integrated Neuromusculoskeletal Release|C1704538|[topp]|["INR"-tx-46-"INR"-noun-0,"INR"-tx-29-"INR"-noun-0]|TX|[6938/3],[7013/3];5086/3|
00000000|MMI|7.81|1+|C3816745|[fndg]|["1+"-tx-30-"1"-integer-0,"1+"-tx-22-"1"-integer-0,"1+"-tx-17-"1"-integer-0]|TX|5252/1;3580/1;1920/1|
00000000|MMI|7.81|1+ Score|C2827734|[qnco]|["1+"-tx-30-"1"-integer-0,"1+"-tx-22-"1"-integer-0,"1+"-tx-17-"1"-integer-0]|TX|5252/1;3580/1;1920/1|
00000000|MMI|7.81|1+ Score, WHO|C2981698|[clas]|["1+"-tx-30-"1"-integer-0,"1+"-tx-22-"1"-integer-0,"1+"-tx-17-"1"-integer-0]|TX|5252/1;3580/1;1920/1|
00000000|MMI|7.80|Clinical Study Follow-up|C3274571|[hlca]|["FOLLOW-UP"-tx-47-"follow up"-adj-0,"FOLLOW-UP"-tx-39-"follow up"-adj-0,"FOLLOW-UP"-tx-21-"FOLLOW UP"-adj-0]|TX|7224/9;6421/9;2379/9|
00000000|MMI|7.80|Follow-Up Report|C1704685|[inpr]|["Follow-Up"-tx-47-"follow up"-adj-0,"Follow-Up"-tx-39-"follow up"-adj-0,"Follow-Up"-tx-21-"FOLLOW UP"-adj-0]|TX|7224/9;6421/9;2379/9|
00000000|MMI|7.80|Follow-up status|C0589120|[fndg]|["Follow-up"-tx-47-"follow up"-adj-0,"Follow-up"-tx-39-"follow up"-adj-0,"Follow-up"-tx-21-"FOLLOW UP"-adj-0]|TX|7224/9;6421/9;2379/9|
00000000|MMI|7.80|follow-up|C1522577|[hlca]|["Follow Up"-tx-47-"follow up"-adj-0,"Follow Up"-tx-39-"follow up"-adj-0,"Follow Up"-tx-21-"FOLLOW UP"-adj-0]|TX|7224/9;6421/9;2379/9|
00000000|MMI|7.79|Niaspan|C1161310|[orch,phsu]|["Niaspan"-tx-27-"niaspan"-noun-0,"Niaspan"-tx-17-"NIASPAN"-noun-0,"Niaspan"-tx-13-"NIASPAN"-noun-0]|TX|4249/7;1922/7;1351/7|
00000000|MMI|7.78|Pulmonary ventilator management|C1315068|[hlca]|["PULM"-tx-42-"PULM"-adj-0,"PULM"-tx-29-"pulm"-adj-0,"PULM"-tx-22-"pulm"-adj-0]|TX|6670/4;5045/4;3236/4|
00000000|MMI|7.78|Edema:Finding:Point in time:^Patient:Ordinal|C1717255|[clna]|["Edema"-tx-29-"edema"-noun-0,"Edema"-tx-27-"edema"-noun-0,"Edema"-tx-22-"edema"-noun-0]|TX|5050/5;4535/5;3241/5|
00000000|MMI|7.73|Endocrine System Findings Domain|C3538926|[idcn]|["ED"-tx-50-"ED"-noun-0,"ED"-tx-35-"ED"-noun-0,"ED"-tx-24-"ED"-noun-0]|TX|7348/2;5968/2;3771/2|
00000000|MMI|7.72|Code|C0805701|[inpr]|["CODE"-tx-47-"CODE"-noun-0,"CODE"-tx-2-"CODE"-noun-0,"CODE"-tx-2-"code"-noun-0]|TX|7119/4;278/4;296/4|
00000000|MMI|7.72|eTMF Content Model Code|C3889831|[inpr]|["Code"-tx-47-"CODE"-noun-0,"Code"-tx-2-"CODE"-noun-0,"Code"-tx-2-"code"-noun-0]|TX|7119/4;278/4;296/4|
00000000|MMI|7.68|Myocardial Infarction ECG Assessment|C3810814|[diap]|["MI"-tx-30-"MI"-noun-0,"MI"-tx-26-"MI"-noun-0,"MI"-tx-22-"MI"-noun-0]|TX|5310/2;3975/2;3418/2|
00000000|MMI|7.67|Presentation|C0449450|[idcn]|["Present"-tx-50-"present"-noun-0,"Presented"-tx-24-"presented"-verb-0,"presentations"-tx-22-"presentations"-noun-0]|TX|7333/7;3753/9;3496/13|
00000000|MMI|7.61|Infusion pump Alert priority PM|C4049155|[fndg]|["PM"-tx-55-"PM"-noun-0,"PM"-tx-36-"pm"-adj-0,"PM"-tx-1-"PM"-adj-0]|TX|7833/2;6014/2;149/2|
00000000|MMI|7.59|Weekly|C0332174|[tmco]|["/week"-tx-48-"week"-noun-0,"/week"-tx-22-"week"-noun-0,"/wk"-tx-22-"wk"-noun-0]|TX|7274/4;2537/4;3582/2|
00000000|MMI|7.59|week|C0439230|[tmco]|["WEEK"-tx-48-"week"-noun-0,"WEEK"-tx-22-"week"-noun-0,"wk"-tx-22-"wk"-noun-0]|TX|7274/4;2537/4;3582/2|
00000000|MMI|7.59|Call (Instruction)|C1947967|[ftcn]|["Call"-tx-49-"call"-noun-0,"Call"-tx-22-"call"-noun-0,"Call"-tx-21-"call"-noun-0]|TX|7306/4;2527/4;2440/4|
00000000|MMI|7.59|Decision|C0679006|[menp]|["Call"-tx-49-"call"-noun-0,"Call"-tx-22-"call"-noun-0,"Call"-tx-21-"call"-noun-0]|TX|7306/4;2527/4;2440/4|
00000000|MMI|7.59|Precursor B-cell lymphoblastic leukemia|C1292769|[neop]|["c all"-tx-49-"call"-noun-0,"c all"-tx-22-"call"-noun-0,"c all"-tx-21-"call"-noun-0]|TX|7306/4;2527/4;2440/4|
00000000|MMI|7.58|Phase|C0205390|[tmco]|["Stage"-tx-29-"stage"-noun-0,"Stage"-tx-26-"stage"-noun-0,"Stage"-tx-22-"stage"-noun-0]|TX|5168/5;4140/5;3569/5|
00000000|MMI|7.58|Stage|C1306673|[qlco]|["Stage"-tx-29-"stage"-noun-0,"Stage"-tx-26-"stage"-noun-0,"Stage"-tx-22-"stage"-noun-0]|TX|5168/5;4140/5;3569/5|
00000000|MMI|7.58|Tumor stage|C1300072|[clna]|["Stage"-tx-29-"stage"-noun-0,"Stage"-tx-26-"stage"-noun-0,"Stage"-tx-22-"stage"-noun-0]|TX|5168/5;4140/5;3569/5|
00000000|MMI|7.54|Mild (qualifier value)|C2945599|[qlco]|["MILD"-tx-36-"Mild"-adj-0,"MILD"-tx-28-"mild"-adj-0]|TX|5985/4;[4589/4],[4644/4]|
00000000|MMI|7.54|Alert|C3665546|[ftcn]|["Alert"-tx-17-"Alert"-adj-0,"Alert"-tx-7-"Alert"-adj-0,"Alert"-tx-2-"Alert"-adj-0]|TX|1983/5;932/5;382/5|
00000000|MMI|7.54|Alert:Type:Point in time:^Patient:Nominal|C3669039|[clna]|["Alert"-tx-17-"Alert"-adj-0,"Alert"-tx-7-"Alert"-adj-0,"Alert"-tx-2-"Alert"-adj-0]|TX|1983/5;932/5;382/5|
00000000|MMI|7.54|Consciousness clear|C0239110|[fndg]|["ALERT"-tx-17-"Alert"-adj-0,"ALERT"-tx-7-"Alert"-adj-0,"ALERT"-tx-2-"Alert"-adj-0]|TX|1983/5;932/5;382/5|
00000000|MMI|7.52|Primary|C0205225|[qlco]|["Primary"-tx-42-"primary"-adj-0,"Main"-tx-37-"Main"-adj-0,"Principal"-tx-22-"PRINCIPAL"-adj-0]|TX|6803/7;6091/4;2602/9|
00000000|MMI|7.50|Date in time|C0011008|[tmco]|["DATE"-tx-48-"date"-noun-0,"DATE"-tx-39-"date"-noun-0]|TX|7293/4;6321/4|
00000000|MMI|7.50|Diagnosis|C0011900|[fndg]|["DIAGNOSIS"-tx-22-"DIAGNOSIS"-noun-0]|TX|[2575/9],[2709/9]|E01
00000000|MMI|7.50|Diagnosis Study|C1704656|[resa]|["DIAGNOSIS"-tx-22-"DIAGNOSIS"-noun-0]|TX|[2575/9],[2709/9]|
00000000|MMI|7.50|MYOTONIC DYSTROPHY 1|C3250443|[dsyn]|["DM"-tx-26-"DM"-noun-0,"DM"-tx-22-"dm"-noun-0]|TX|4048/2;2872/2|
00000000|MMI|7.50|VIT gene|C1421454|[gngm]|["VIT"-tx-20-"VIT"-noun-0,"VIT"-tx-13-"VIT"-noun-0]|TX|2134/3;1449/3|
00000000|MMI|7.50|Vitamin B3 Assay|C1142562|[lbpr]|["Niacin"-tx-20-"NIACIN"-noun-0,"Niacin"-tx-13-"NIACIN"-noun-0]|TX|2125/6;1440/6|
00000000|MMI|7.50|orders - HL7PublishingDomain|C3244315|[inpr]|["orders"-tx-55-"ORDERS"-verb-0,"orders"-tx-1-"ORDERS"-verb-0]|TX|7860/6;49/6|
00000000|MMI|7.48|Numerous|C0439064|[qnco]|["MULTIPLE"-tx-22-"multiple"-adj-0,"Several"-tx-22-"several"-adj-0]|TX|[3425/8],[3480/8];3643/7|
00000000|MMI|7.42|Bone Tissue|C0391978|[tisu]|["BONE"-tx-1-"BONING"-noun-0]|TX|63/6|A02.835.232;A10.165.265
00000000|MMI|7.15|Appointments|C0003629|[idcn]|["Appointment"-tx-21-"APPOINTMENT"-noun-0]|TX|2389/11|N04.452.095
00000000|MMI|7.12|prevention & control|C0033107|[inpr]|["prophylaxis"-tx-52-"prophylaxis"-noun-0]|TX|7704/11|x.x.x
00000000|MMI|7.11|Stenosis|C1261287|[patf]|["Stenosis"-tx-22-"stenosis"-noun-0]|TX|3173/8|C23.300.287
00000000|MMI|7.08|Nasal sinus|C0030471|[bsoj]|["Sinus"-tx-29-"sinus"-noun-0]|TX|4917/5|A04.531.621
00000000|MMI|7.08|pathologic fistula|C0016169|[anab]|["Sinus"-tx-29-"sinus"-noun-0]|TX|4917/5|C23.300.575
00000000|MMI|7.05|Peripheral Vascular Diseases|C0085096|[dsyn]|["pvd"-tx-26-"PVD"-noun-0]|TX|4059/3|C14.907.617
00000000|MMI|7.04|Germany|C0017480|[geoa]|["GM"-tx-17-"GM"-noun-0]|TX|1971/2|Z01.542.315;Z01.586.315
00000000|MMI|7.04|Abdomen|C0000726|[blor]|["abd"-tx-27-"abd"-noun-0]|TX|4512/3|A01.923.047
00000000|MMI|7.03|Sore Throat|C0242429|[sosy]|["Throat discomfort"-tx-25-"throat discomfort"-noun-0]|TX|3939/6,3950/10|C07.550.781;C08.730.561;C09.775.649
00000000|MMI|6.02|Allergic Reaction|C1527304|[patf]|["Allergy"-tx-22-"ALLERGY"-noun-0]|TX|2556/7|C20.543
00000000|MMI|6.02|Hypersensitivity|C0020517|[patf]|["ALLERGY"-tx-22-"ALLERGY"-noun-0]|TX|2556/7|C20.543
00000000|MMI|6.02|Infection|C3714514|[patf]|["Infections"-tx-22-"Infections"-noun-0]|TX|2732/10|C01.539
00000000|MMI|6.02|Patients|C0030705|[podg]|["*^patient"-tx-39-"patient"-noun-0]|TX|6408/7|M01.643
00000000|MMI|5.76|Hold (action)|C1948035|[acty]|["Hold"-tx-51-"holding"-verb-0,"Hold"-tx-46-"holding"-verb-0]|TX|7494/7;7046/7|
00000000|MMI|5.76|Hold - dosing instruction fragment|C1553387|[idcn]|["Hold"-tx-51-"holding"-verb-0,"Hold"-tx-46-"holding"-verb-0]|TX|7494/7;7046/7|
00000000|MMI|5.76|hold - Data Operation|C3853841|[ftcn]|["hold"-tx-51-"holding"-verb-0,"hold"-tx-46-"holding"-verb-0]|TX|7494/7;7046/7|
00000000|MMI|5.54|Arylsulfatase A, human|C3853627|[aapp,enzy]|["ASA"-tx-32-"ASA"-noun-0,"ASA"-tx-27-"asa"-noun-0]|TX|5399/3;4227/3|
00000000|MMI|5.47|+5|C0728893|[qnco]|["+5"-tx-45-"5"-integer-0,"+5"-tx-1-"5"-fraction-0]|TX|6856/1;16/1|
00000000|MMI|5.47|>5|C0439084|[qnco]|[">5"-tx-45-"5"-integer-0,">5"-tx-1-"5"-fraction-0]|TX|6856/1;16/1|
00000000|MMI|5.47|Condition|C0348080|[qlco]|["Condition"-tx-51-"CONDITION"-noun-0,"Condition"-tx-22-"Conditions"-noun-0]|TX|7393/9;2719/10|
00000000|MMI|5.47|Condition:Find:Pt:^Patient:Nom|C3864998|[clna]|["Condition"-tx-51-"CONDITION"-noun-0,"Condition"-tx-22-"Conditions"-noun-0]|TX|7393/9;2719/10|
00000000|MMI|5.47|Logical Condition|C1705253|[cnce]|["Condition"-tx-51-"CONDITION"-noun-0,"Condition"-tx-22-"Conditions"-noun-0]|TX|7393/9;2719/10|
00000000|MMI|5.43|Dental|C0226984|[qlco]|["DENTAL"-tx-52-"dental"-adj-0,"DENTAL"-tx-39-"dental"-adj-0]|TX|7667/6;6351/6|
00000000|MMI|5.42|Negative - answer|C3853545|[qlco]|["Negative"-tx-30-"negative"-noun-0,"NEG"-tx-29-"neg"-noun-0]|TX|5281/8;4883/3|
00000000|MMI|5.39|Limited (extensiveness)|C0439801|[ftcn]|["limits"-tx-31-"limits"-verb-0,"Limited"-tx-29-"limited"-verb-0]|TX|5379/6;4785/7|
00000000|MMI|5.33|Office|C0442603|[mnob]|["Office"-tx-50-"office"-noun-0,"Office"-tx-21-"office"-noun-0]|TX|7323/6;2445/6|
00000000|MMI|5.26|First (number)|C0205435|[qnco]|["First"-tx-41-"first"-noun-0,"1st"-tx-29-"1st"-numeric_ordinal-0]|TX|6610/5;4975/3|
00000000|MMI|5.26|Left coronary artery structure|C1261082|[bpoc]|["LM"-tx-33-"LM"-noun-0,"Left Main Coronary Artery"-tx-33-"Left Main Coronary Artery"-noun-0]|TX|5498/2;5457/25|
00000000|MMI|5.26|Restricted|C0443288|[ftcn]|["restrict"-tx-45-"restrict"-verb-0,"Restriction"-tx-21-"restriction"-noun-0]|TX|6894/8;2246/11|
00000000|MMI|5.25|C-Circle|C3538933|[celc]|["CC"-tx-29-"CC"-noun-0,"CC"-tx-22-"CC"-noun-0]|TX|5096/2;3381/2|
00000000|MMI|5.25|Cardiovascular System Findings Domain|C3538987|[idcn]|["CV"-tx-30-"CV"-noun-0,"CV"-tx-21-"CV"-noun-0]|TX|5256/2;2479/2|
00000000|MMI|5.25|Total abdominal hysterectomy with bilateral salpingo-oophorectomy|C0542407|[topp]|["tah bso"-tx-26-"TAH/BSO"-noun-0,"tah bso"-tx-22-"TAH/BSO"-noun-0]|TX|4097/7;3056/7|
00000000|MMI|5.23|Borg Category-Ratio 10 Perceived Exertion Score 3|C4049706|[inpr]|["Moderate"-tx-33-"Moderate"-adj-0,"Moderate"-tx-22-"moderate"-verb-0]|TX|5736/8;3456/8|
00000000|MMI|5.23|Moderate (severity modifier)|C0205081|[qlco]|["Moderate"-tx-33-"Moderate"-adj-0,"Moderate"-tx-22-"moderate"-verb-0]|TX|5736/8;3456/8|
00000000|MMI|5.23|Moderate Extremity Pain|C4049705|[inpr]|["Moderate"-tx-33-"Moderate"-adj-0,"Moderate"-tx-22-"moderate"-verb-0]|TX|5736/8;3456/8|
00000000|MMI|5.23|Moderation|C1881878|[qlco]|["MODERATE"-tx-33-"Moderate"-adj-0,"MODERATE"-tx-22-"moderate"-verb-0]|TX|5736/8;3456/8|
00000000|MMI|5.22|Summary (document)|C1706244|[inpr]|["Summary"-tx-52-"summary"-noun-0,"Summary"-tx-1-"SUMMARY"-noun-0]|TX|7751/7;223/7|
00000000|MMI|5.22|summary - ActRelationshipSubset|C1552616|[inpr]|["summary"-tx-52-"summary"-noun-0,"summary"-tx-1-"SUMMARY"-noun-0]|TX|7751/7;223/7|
00000000|MMI|5.21|Cleared by|C0521097|[ftcn]|["cleared"-tx-47-"cleared"-verb-0,"cleared"-tx-39-"cleared"-verb-0]|TX|7187/7;6370/7|
00000000|MMI|5.20|Total Amyloid Precursor Protein Measurement|C3887695|[lbpr]|["APPT"-tx-22-"appt"-noun-0,"APPT"-tx-21-"appt"-noun-0]|TX|2546/4;2460/4|
00000000|MMI|5.20|Content Type Requirement|C3889426|[ftcn]|["Requirement"-tx-42-"requirement"-noun-0,"Requirement"-tx-22-"requirements"-noun-0]|TX|6682/11;3605/12|
00000000|MMI|5.20|Instruction [Publication Type]|C0302828|[inpr]|["Instruction"-tx-16-"Instruction"-noun-0,"Instruction"-tx-10-"Instruction"-noun-0]|TX|1816/11;1195/11|
00000000|MMI|5.20|Instructions|C1442085|[idcn]|["instruction"-tx-16-"Instruction"-noun-0,"instruction"-tx-10-"Instruction"-noun-0]|TX|1816/11;1195/11|
00000000|MMI|5.19|Pyrexia of unknown origin (excl puerperal)|C0856281|[sosy]|["puo"-tx-35-"PUO"-noun-1,"puo"-tx-24-"PUO"-noun-0]|TX|5978/3;3828/3|
00000000|MMI|5.19|0%|C3842591|[fndg]|["0%"-tx-46-"0"-real_number-0,"0%"-tx-26-"0"-integer-0]|TX|7022/1;4136/1|
00000000|MMI|5.18|Discontinued|C1444662|[fndg]|["D/C"-tx-51-"d/c"-noun-0,"D/C"-tx-1-"D/C"-noun-0]|TX|7425/3;194/3|
00000000|MMI|5.18|Doctor of Chiropractic|C1512015|[inpr]|["D.C."-tx-51-"d/c"-noun-0,"D.C."-tx-1-"D/C"-noun-0]|TX|7425/3;194/3|
00000000|MMI|5.18|Furosemide:Mass:Pt:Dose:Qn|C0366492|[clna]|["Furosemide Dose"-tx-51-"lasix dose"-noun-0,"Furosemide Dose"-tx-37-"lasix dose"-noun-0]|TX|7462/10;6133/10|
00000000|MMI|5.16|history of - * (non-specific)|C0455483|[fndg]|["h o"-tx-22-"h/o"-noun-0]|TX|[3534/3],[3585/3]|
00000000|MMI|5.13|Cholesterol measurement test|C0201950|[lbpr]|["CHOL"-tx-26-"chol"-noun-0,"CHOL"-tx-21-"chol"-noun-0]|TX|4035/4;2276/4|
00000000|MMI|5.13|20%|C3842589|[fndg]|["20%"-tx-27-"20"-integer-0,"20%"-tx-21-"20"-integer-0]|TX|4350/2;2197/2|
00000000|MMI|5.10|Attending (action)|C1999232|[ftcn]|["attending"-tx-1-"Attending"-adj-0,"attending"-tx-1-"Attending"-noun-0]|TX|[168/9],[236/9];[168/9],[236/9]|
00000000|MMI|5.10|Attending (provider role)|C1547429|[prog]|["Attending"-tx-1-"Attending"-adj-0,"Attending"-tx-1-"Attending"-noun-0]|TX|[168/9],[236/9];[168/9],[236/9]|
00000000|MMI|5.09|Ostium|C0444567|[bsoj]|["Ostium"-tx-34-"ostial"-adj-0,"Ostium"-tx-33-"Ostial"-adj-0]|TX|5828/6;5673/6|
00000000|MMI|5.09|Before|C0332152|[tmco]|["Prior"-tx-51-"prior"-adj-0,"Prior to"-tx-39-"prior to"-prep-0]|TX|7440/5;6252/8|
00000000|MMI|5.09|Dose number:Number:Point in time:^Patient:Quantitative|C1114758|[clna]|["Dose #"-tx-36-"dose"-noun-0,"Dose number"-tx-17-"Number Doses"-noun-0]|TX|6017/4;1878/6,1888/5|
00000000|MMI|5.09|Therapeutic procedure|C0087111|[topp]|["Therapeutic"-tx-46-"therapeutic"-adj-0,"Treatment"-tx-22-"Treatment"-noun-0]|TX|6942/11;2771/9|E02
00000000|MMI|5.08|Patient Condition Code - Stable|C1547311|[inpr]|["Stable"-tx-51-"Stable"-adj-0,"Stable"-tx-42-"stable"-adj-0]|TX|7404/6;6792/6|
00000000|MMI|5.08|Stable status|C0205360|[qlco]|["STABLE"-tx-51-"Stable"-adj-0,"STABLE"-tx-42-"stable"-adj-0]|TX|7404/6;6792/6|
00000000|MMI|5.07|GLAUCOMA, NORMAL TENSION, SUSCEPTIBILITY TO (finding)|C1847730|[fndg]|["NTG"-tx-52-"NTG"-noun-0,"NTG"-tx-23-"NTG"-noun-1]|TX|7616/3;3735/3|
00000000|MMI|5.07|OPA1 gene|C1417953|[gngm]|["NTG"-tx-52-"NTG"-noun-0,"NTG"-tx-23-"NTG"-noun-0]|TX|7616/3;3735/3|
00000000|MMI|5.07|Curriculum Vitae|C1880201|[inpr]|["Resume"-tx-22-"RESUME"-noun-0,"Resume"-tx-21-"Resume"-noun-0]|TX|3354/6;2355/6|
00000000|MMI|5.07|Resume - Remote control command|C1550028|[idcn]|["Resume"-tx-22-"RESUME"-noun-0,"Resume"-tx-21-"Resume"-noun-0]|TX|3354/6;2355/6|
00000000|MMI|5.07|resume - DataOperation|C3242342|[ftcn]|["resume"-tx-22-"RESUME"-noun-0,"resume"-tx-21-"Resume"-noun-0]|TX|3354/6;2355/6|
00000000|MMI|5.05|Shortened|C1282927|[qlco]|["short"-tx-41-"short"-prep-0,"brief"-tx-22-"BRIEF"-adj-0]|TX|6570/5;3348/5|
00000000|MMI|5.05|Full|C0443225|[qlco]|["Full"-tx-47-"FULL"-adj-0,"Full"-tx-2-"Full"-adj-0]|TX|7114/4;291/4|
00000000|MMI|5.04|Evaluation procedure|C1261322|[hlca]|["Evaluation"-tx-39-"evaluation"-noun-0,"Evaluation"-tx-1-"evaluation"-noun-0]|TX|6276/10;178/10|
00000000|MMI|5.04|((5,6-dichloro-2,3,9,9a-tetrahydro-3-oxo-9a-propyl-1H-fluoren-7-yl)oxy)acetic acid|C0378071|[orch,phsu]|["b-3"-tx-21-"B-3"-adj-0,"b-3"-tx-14-"B-3"-adj-0]|TX|2139/3;1454/3|
00000000|MMI|5.03|Decompensated|C0205434|[qlco]|["Decompensated"-tx-29-"decompensated"-adj-0,"Decompensated"-tx-22-"decompensated"-adj-0]|TX|5205/13;3514/13|
00000000|MMI|5.01|Missing Value Reason|C1709044|[qlco]|["MVR"-tx-40-"MVR"-noun-0,"MVR"-tx-39-"MVR"-noun-0]|TX|6498/3;6233/3|
00000000|MMI|5.00|Anti-Drug Antibody|C3811629|[aapp,imft]|["ADA"-tx-45-"ADA"-noun-0,"ADA"-tx-21-"ADA"-noun-0]|TX|6873/3;2308/3|
00000000|MMI|5.00|Genus Ada|C1060325|[plnt]|["Ada"-tx-45-"ADA"-noun-0,"Ada"-tx-21-"ADA"-noun-0]|TX|6873/3;2308/3|
00000000|MMI|5.00|House (environment)|C2003847|[mnob]|["House"-tx-21-"House"-noun-0]|TX|[2264/5],[2300/5]|
00000000|MMI|4.99|Regimen - CHV concept|C2945654|[inpr]|["regimen"-tx-51-"regimen"-noun-0,"regimen"-tx-37-"regimen"-noun-0]|TX|7446/7;6106/7|
00000000|MMI|4.96|Adjacent|C0205117|[spco]|["next"-tx-48-"next"-adj-0,"next"-tx-22-"next"-adj-0]|TX|7269/4;2532/4|
00000000|MMI|4.96|Following|C0332282|[tmco]|["Next"-tx-48-"next"-adj-0,"Next"-tx-22-"next"-adj-0]|TX|7269/4;2532/4|
00000000|MMI|4.96|Then|C1883708|[tmco]|["Next"-tx-48-"next"-adj-0,"Next"-tx-22-"next"-adj-0]|TX|7269/4;2532/4|
00000000|MMI|4.87|Body Fluids|C0005889|[bdsu]|["FLUID"-tx-45-"fluid"-noun-0]|TX|6888/5|A12.207
00000000|MMI|4.85|Catheterization|C0007430|[topp]|["Catheterization"-tx-46-"catheterization"-noun-0]|TX|7028/15|E02.148;E05.157
00000000|MMI|4.77|Heart|C0018787|[bpoc]|["Cardiac"-tx-45-"cardiac"-adj-0]|TX|6865/7|A07.541
00000000|MMI|4.77|Salts|C0036140|[chvs]|["Salt"-tx-45-"salt"-noun-0]|TX|6880/4|D01.786
00000000|MMI|3.74|(City) Block|C1706084|[geoa]|["Block"-tx-25-"blocks"-verb-0]|TX|3861/6|
00000000|MMI|3.74|1 - 3|C3843504|[fndg]|["1 - 3"-tx-7-"1/3"-fraction-0]|TX|876/3|
00000000|MMI|3.74|1/5|C0450316|[qnco]|["1/5"-tx-25-"1.5"-real_number-0]|TX|3857/3|
00000000|MMI|3.74|3+ Answer to Question|C3838680|[fndg]|["3+"-tx-42-"3"-integer-0]|TX|6696/1|
00000000|MMI|3.74|3+ Score|C2827736|[qnco]|["3+"-tx-42-"3"-integer-0]|TX|6696/1|
00000000|MMI|3.74|3+ Score, WHO|C2981702|[clas]|["3+"-tx-42-"3"-integer-0]|TX|6696/1|
00000000|MMI|3.74|4+ Answer to question|C3838679|[fndg]|["4+"-tx-42-"4"-integer-0]|TX|6764/1|
00000000|MMI|3.74|<3 (qualifier value)|C0439086|[qnco]|["<3"-tx-42-"3"-integer-0]|TX|6696/1|
00000000|MMI|3.74|Abortion consent:Finding:Point in time:^Patient:Document|C2360836|[clna]|["Patient"-tx-39-"patient"-noun-0]|TX|6408/7|
00000000|MMI|3.74|ActInformationPrivacyReason <operations>|C3244305|[ftcn]|["operations"-tx-22-"OPERATIONS"-noun-0]|TX|3267/10|
00000000|MMI|3.74|Additional comments|C1830770|[fndg]|["Additional comments"-tx-47-"ADDITIONAL COMMENTS"-noun-0]|TX|7152/19|
00000000|MMI|3.74|Affecting|C0392760|[ftcn]|["Affecting"-tx-22-"affecting"-verb-0]|TX|2761/9|
00000000|MMI|3.74|All|C0444868|[qnco]|["ALL"-tx-27-"ALL"-noun-0]|TX|4179/3|
00000000|MMI|3.74|Allergic disposition|C3539909|[dsyn]|["Allergy"-tx-22-"ALLERGY"-noun-0]|TX|2556/7|
00000000|MMI|3.74|Allergy - Physicians|C1554743|[prog]|["Allergy"-tx-22-"ALLERGY"-noun-0]|TX|2556/7|
00000000|MMI|3.74|Ambulate|C4036205|[fndg]|["Ambulate"-tx-25-"ambulates"-verb-0]|TX|3847/9|
00000000|MMI|3.74|Approximate|C0332232|[qlco]|["Approximate"-tx-17-"approximate"-adj-0]|TX|1905/11|
00000000|MMI|3.74|Associated Persons Domain|C3887950|[inpr]|["AP"-tx-29-"AP"-noun-0]|TX|5036/2|
00000000|MMI|3.74|Basal Cell Carcinoma Pathway|C2984322|[ftcn]|["Basal cell carcinoma"-tx-22-"basal cell carcinoma"-noun-0]|TX|3103/20|
00000000|MMI|3.74|Biomedical Monitors|C0181904|[medd]|["Monitor"-tx-41-"monitor"-verb-0]|TX|6530/7|
00000000|MMI|3.74|Block (unit of measure)|C2828370|[qnco]|["Block"-tx-25-"blocks"-verb-0]|TX|3861/6|
00000000|MMI|3.74|Block Specimens|C1533157|[sbst]|["Blocks"-tx-25-"blocks"-verb-0]|TX|3861/6|
00000000|MMI|3.74|Block Unit of Distance|C3811660|[qnco]|["BLOCKS"-tx-25-"blocks"-verb-0]|TX|3861/6|
00000000|MMI|3.74|Blocking|C0332206|[ftcn]|["blocks"-tx-25-"blocks"-verb-0]|TX|3861/6|
00000000|MMI|3.74|Bound (value)|C2349209|[cnce]|["Limit"-tx-31-"limits"-verb-0]|TX|5379/6|
00000000|MMI|3.74|Bounded by|C0332297|[spco]|["BB"-tx-32-"BB"-noun-0]|TX|5405/2|
00000000|MMI|3.74|Carcinoma of lung|C0684249|[neop]|["-- Lung Cancer"-tx-22-"lung cancer"-noun-0]|TX|3023/11|
00000000|MMI|3.74|Cardiac Lead Procedure|C3275067|[topp]|["LEAD"-tx-31-"leads"-verb-0]|TX|5373/5|
00000000|MMI|3.74|Checking (action)|C1283174|[acty]|["Check"-tx-41-"check"-verb-0]|TX|6552/5|
00000000|MMI|3.74|Complication|C0009566|[patf]|["Complications"-tx-22-"Complications"-noun-0]|TX|2745/13|
00000000|MMI|3.74|Container status - Identified|C1550043|[fndg]|["Identified"-tx-33-"identified"-verb-1]|TX|5509/10|
00000000|MMI|3.74|Continuous|C0549178|[idcn]|["Continued"-tx-32-"continued"-verb-0]|TX|5423/9|
00000000|MMI|3.74|Diagnostic Specificity|C1511884|[qnco]|["Specificity"-tx-31-"specificity"-noun-0]|TX|5386/11|
00000000|MMI|3.74|Dietary Lead|C2348269|[elii]|["Lead"-tx-31-"leads"-verb-0]|TX|5373/5|
00000000|MMI|3.74|Discharge date|C2361123|[tmco]|["Discharge date"-tx-1-"Discharge Date"-noun-0]|TX|0/14|
00000000|MMI|3.74|Discharge date:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative|C2361122|[clna]|["Discharge date"-tx-1-"Discharge Date"-noun-0]|TX|0/14|
00000000|MMI|3.74|Experimental Organism Basal Cell Carcinoma|C3811653|[neop]|["Basal Cell Carcinoma"-tx-22-"basal cell carcinoma"-noun-0]|TX|3103/20|
00000000|MMI|3.74|Extended Release Dosage Form|C1707968|[bodm]|["Extended Release"-tx-16-"EXTENDED RELEASE"-adj-0]|TX|1760/16|
00000000|MMI|3.74|Firstly|C1279901|[qlco]|["First"-tx-41-"first"-noun-0]|TX|6610/5|
00000000|MMI|3.74|Fix|C3714578|[phpr]|["Fixed"-tx-29-"fixed"-verb-0]|TX|4839/5|
00000000|MMI|3.74|Fixed Specimen|C2827483|[bdsu]|["Fixed"-tx-29-"fixed"-verb-0]|TX|4839/5|
00000000|MMI|3.74|Fixed behavior|C0443218|[qlco]|["Fixed"-tx-29-"fixed"-verb-0]|TX|4839/5|
00000000|MMI|3.74|Former smoker|C0337671|[fndg]|["Former Smoker"-tx-27-"former smoker"-noun-0]|TX|4384/13|
00000000|MMI|3.74|GORAB gene|C1822658|[gngm]|["GO"-tx-39-"go"-verb-0]|TX|6392/2|
00000000|MMI|3.74|GRAPEFRUIT EXTRACT|C0440280|[orch,phsu]|["GRAPEFRUIT"-tx-10-"grapefruit"-noun-0]|TX|1213/10|
00000000|MMI|3.74|Grapefruit (food)|C0995150|[food]|["GRAPEFRUIT"-tx-10-"grapefruit"-noun-0]|TX|1213/10|
00000000|MMI|3.74|Grapefruit Flavor|C1365950|[food]|["GRAPEFRUIT"-tx-10-"grapefruit"-noun-0]|TX|1213/10|
00000000|MMI|3.74|HL7PublishingSubSection <operations>|C3244306|[inpr]|["operations"-tx-22-"OPERATIONS"-noun-0]|TX|3267/10|
00000000|MMI|3.74|Hypertension Adverse Event|C1963138|[fndg]|["Hypertension"-tx-22-"hypertension"-noun-0]|TX|2857/12|
00000000|MMI|3.74|Hysterectomy consent:Finding:Point in time:^Patient:Document|C2360838|[clna]|["Patient"-tx-39-"patient"-noun-0]|TX|6408/7|
00000000|MMI|3.74|Identified|C0205396|[qlco]|["Identified"-tx-33-"identified"-verb-0]|TX|5509/10|
00000000|MMI|3.74|Increase|C0442805|[ftcn]|["Increased"-tx-22-"increased"-verb-0]|TX|3589/9|
00000000|MMI|3.74|Increased|C0205217|[qnco]|["Increased"-tx-22-"increased"-verb-0]|TX|3589/9|
00000000|MMI|3.74|Information|C1533716|[idcn]|["INFORMATION"-tx-14-"information"-noun-0]|TX|1506/11|
00000000|MMI|3.74|Interventional procedure|C0184661|[topp]|["PROCEDURES"-tx-22-"PROCEDURES"-noun-0]|TX|3282/10|
00000000|MMI|3.74|Involvement with|C1314939|[ftcn]|["Affecting"-tx-22-"affecting"-verb-0]|TX|2761/9|
00000000|MMI|3.74|Lateral|C0205093|[spco]|["LATERAL"-tx-31-"lateral"-adj-0]|TX|5365/7|
00000000|MMI|3.74|Leading|C1522538|[ftcn]|["Lead"-tx-31-"leads"-verb-0]|TX|5373/5|
00000000|MMI|3.74|Leads (device)|C0181586|[medd]|["leads"-tx-31-"leads"-verb-0]|TX|5373/5|
00000000|MMI|3.74|Limit - Amount class|C1549649|[idcn]|["Limit"-tx-31-"limits"-verb-0]|TX|5379/6|
00000000|MMI|3.74|Make - Instruction Imperative|C1881534|[ftcn]|["Make"-tx-21-"make"-verb-0]|TX|2455/4|
00000000|MMI|3.74|Malignant neoplasm of endometrium|C0007103|[neop]|["Endometrial cancer"-tx-22-"endometrial cancer"-noun-0]|TX|3066/18|
00000000|MMI|3.74|Malignant neoplasm of lung|C0242379|[neop]|["Lung Cancer"-tx-22-"lung cancer"-noun-0]|TX|3023/11|
00000000|MMI|3.74|Medical History|C0262926|[fndg]|["PMH"-tx-26-"PMH"-noun-0]|TX|3962/3|
00000000|MMI|3.74|Medications:-:Point in time:^Patient:-|C2598133|[clna]|["Medications"-tx-2-"MEDICATIONS"-noun-0]|TX|341/11|
00000000|MMI|3.74|Medications:Presence or Identity:Duration of the study:^Patient:Nominal|C0802604|[clna]|["Medications"-tx-2-"MEDICATIONS"-noun-0]|TX|341/11|
00000000|MMI|3.74|Middle|C0444598|[spco]|["Mid"-tx-33-"Mid"-adj-0]|TX|5709/3|
00000000|MMI|3.74|Monday|C0585024|[tmco]|["Monday"-tx-52-"Monday"-noun-0]|TX|7594/6|
00000000|MMI|3.74|Monitor Device Component|C1704646|[mnob]|["Monitor"-tx-41-"monitor"-verb-0]|TX|6530/7|
00000000|MMI|3.74|Monitor, occupation|C1521743|[prog]|["Monitor"-tx-41-"monitor"-verb-0]|TX|6530/7|
00000000|MMI|3.74|Monitoring Device|C0596972|[medd]|["Monitor"-tx-41-"monitor"-verb-0]|TX|6530/7|
00000000|MMI|3.74|NADPH:sulfur oxidoreductase activity|C2700623|[moft]|["NSR"-tx-42-"NSR"-noun-0]|TX|6634/3|
00000000|MMI|3.74|NCI CTEP SDC Basal Cell Carcinoma Sub-Category Terminology|C3540686|[inpr]|["Basal Cell Carcinoma"-tx-22-"basal cell carcinoma"-noun-0]|TX|3103/20|
00000000|MMI|3.74|Negative|C0205160|[qlco]|["Negative"-tx-30-"negative"-noun-0]|TX|5281/8|
00000000|MMI|3.74|Negative Charge|C2825491|[qlco]|["Negative"-tx-30-"negative"-noun-0]|TX|5281/8|
00000000|MMI|3.74|Negative Finding|C1513916|[fndg]|["NEGATIVE"-tx-30-"negative"-noun-0]|TX|5281/8|
00000000|MMI|3.74|Negative Number|C2825415|[cnce]|["Negative"-tx-30-"negative"-noun-0]|TX|5281/8|
00000000|MMI|3.74|Neutral Sidebent Rotated|C1704493|[patf]|["NSR"-tx-42-"NSR"-noun-0]|TX|6634/3|
00000000|MMI|3.74|Never (frequency)|C2003901|[tmco]|["NEVER"-tx-25-"never"-adv-0]|TX|3898/5|
00000000|MMI|3.74|Nicotinic Acid Drug Class|C3714626|[phsu,vita]|["NICOTINIC ACID"-tx-17-"NICOTINIC ACID"-noun-0]|TX|1932/14|
00000000|MMI|3.74|Nicotinic Acid [EPC]|C3536880|[phsu]|["Nicotinic Acid"-tx-17-"NICOTINIC ACID"-noun-0]|TX|1932/14|
00000000|MMI|3.74|Obstruction|C0028778|[patf]|["blocks"-tx-25-"blocks"-verb-0]|TX|3861/6|
00000000|MMI|3.74|PPP4C gene|C1418850|[gngm]|["PPX"-tx-46-"Ppx"-noun-0]|TX|6933/3|
00000000|MMI|3.74|Patient in hospital|C0701159|[fndg]|["HOSPITALIZED"-tx-36-"hospitalized"-verb-0]|TX|6039/12|
00000000|MMI|3.74|Pharmaceutical Preparations|C0013227|[phsu]|["Medications"-tx-2-"MEDICATIONS"-noun-0]|TX|341/11|D26
00000000|MMI|3.74|Platelet Activating Factor Measurement|C3811388|[lbpr]|["PAF"-tx-26-"PAF"-noun-0]|TX|4053/3|
00000000|MMI|3.74|Plumbum metallicum, homeopathic preparation|C1442948|[inch,phsu]|["lead"-tx-31-"leads"-verb-0]|TX|5373/5|
00000000|MMI|3.74|Positive|C1446409|[qlco]|["ruled"-tx-30-"ruled"-verb-0]|TX|5293/5|
00000000|MMI|3.74|Preventive monitoring|C0150369|[hlca]|["monitor"-tx-41-"monitor"-verb-0]|TX|6530/7|
00000000|MMI|3.74|Primary malignant neoplasm of lung|C1306460|[neop]|["Lung cancer"-tx-22-"lung cancer"-noun-0]|TX|3023/11|
00000000|MMI|3.74|Procedure (set of actions)|C2700391|[acty]|["Procedures"-tx-22-"PROCEDURES"-noun-0]|TX|3282/10|
00000000|MMI|3.74|Proximal|C0205107|[spco]|["PROXIMAL"-tx-33-"Proximal"-adj-0]|TX|5558/8|
00000000|MMI|3.74|Pump Device Component|C1706421|[mnob]|["Pump"-tx-35-"PUMP"-noun-0]|TX|5871/4|
00000000|MMI|3.74|Reduced|C0392756|[qlco]|["Reduced"-tx-37-"reduced"-verb-0]|TX|6125/7|
00000000|MMI|3.74|Response to antigens|C1314973|[phsf]|["ALLERGY"-tx-22-"ALLERGY"-noun-0]|TX|2556/7|
00000000|MMI|3.74|Rhythm|C0871269|[fndg]|["Rhythm"-tx-42-"RHYTHM"-noun-0]|TX|6626/6|
00000000|MMI|3.74|Rhythm Not Otherwise Specified ECG Assessment|C3828331|[inpr]|["Rhythm Not Otherwise Specified"-tx-42-"RHYTHM"-noun-0]|TX|6626/6|
00000000|MMI|3.74|S prime|C2603362|[clna]|["S'"-tx-21-"("-noun-0]|TX|2400/1|
00000000|MMI|3.74|Schedule (document type)|C0086960|[inpr]|["Schedule"-tx-48-"schedule"-verb-0]|TX|7282/8|
00000000|MMI|3.74|See|C1947903|[acty]|["See"-tx-41-"see"-verb-0]|TX|6589/3|
00000000|MMI|3.74|Set scale|C1442518|[ftcn]|["Set"-tx-30-"sets"-verb-0]|TX|5276/4|
00000000|MMI|3.74|Sterilization consent:Finding:Point in time:^Patient:Document|C2360840|[clna]|["Patient"-tx-39-"patient"-noun-0]|TX|6408/7|
00000000|MMI|3.74|Sustained Release Dosage Form|C1710261|[bodm]|["Sustained Release"-tx-17-"SUSTAINED RELEASE"-adj-0]|TX|1947/17|
00000000|MMI|3.74|TAC1 wt Allele|C1705924|[gngm]|["NKA"-tx-22-"NKA"-noun-0]|TX|2565/3|
00000000|MMI|3.74|TCAP gene|C1420621|[gngm]|["TELE"-tx-42-"tele"-noun-0]|TX|6643/4|
00000000|MMI|3.74|Take|C1515187|[hlca]|["Take"-tx-16-"Take"-verb-0]|TX|1828/4|
00000000|MMI|3.74|Telephone Number|C1515258|[cnce]|["Tele"-tx-42-"tele"-noun-0]|TX|6643/4|
00000000|MMI|3.74|Tissue Type Code - Basal cell carcinoma|C1547219|[inpr]|["Basal cell carcinoma"-tx-22-"basal cell carcinoma"-noun-0]|TX|3103/20|
00000000|MMI|3.74|Universal restriction modifier (core metadata concept)|C3539085|[idcn]|["All"-tx-27-"ALL"-noun-0]|TX|4179/3|
00000000|MMI|3.74|Usage|C0457083|[ftcn]|["uses"-tx-25-"uses"-verb-0]|TX|3904/4|
00000000|MMI|3.74|Use - dosing instruction imperative|C1947944|[inpr]|["Use"-tx-25-"uses"-verb-0]|TX|3904/4|
00000000|MMI|3.74|Uterine Corpus Cancer|C1883486|[neop]|["Endometrial Cancer"-tx-22-"endometrial cancer"-noun-0]|TX|3066/18|
00000000|MMI|3.74|Warmer, device|C0184348|[medd]|["Warm"-tx-27-"warm"-verb-0]|TX|4527/4|
00000000|MMI|3.74|cancelled action|C0205544|[qlco]|["Cancelled"-tx-39-"cancelled"-verb-0]|TX|6326/9|
00000000|MMI|3.74|metoprolol succinate|C0724633|[orch,phsu]|["METOPROLOL SUCCINATE"-tx-16-"METOPROLOL SUCCINATE"-noun-0]|TX|1739/20|
00000000|MMI|3.74|per second|C0565930|[qnco]|["/s"-tx-21-"("-noun-0]|TX|2400/1|
00000000|MMI|3.74|pump (device)|C0182537|[medd]|["Pump"-tx-35-"PUMP"-noun-0]|TX|5871/4|
00000000|MMI|3.74|rhythmic process (biological)|C1523018|[phsf]|["rhythm"-tx-42-"RHYTHM"-noun-0]|TX|6626/6|
00000000|MMI|3.74|set (group)|C1705195|[cnce]|["Set"-tx-30-"sets"-verb-0]|TX|5276/4|
00000000|MMI|3.74|treatments and procedures|C0237403|[topp]|["treatments procedures"-tx-22-"TREATMENTS/PROCEDURES"-noun-0]|TX|3305/21|
00000000|MMI|3.74|warming process|C0687712|[npop]|["warm"-tx-27-"warm"-verb-0]|TX|4527/4|
00000000|MMI|2.87|Entire bone (organ)|C1266908|[bpoc]|["Bone, NOS"-tx-1-"BONING"-noun-0]|TX|63/6|
00000000|MMI|2.87|Entire bony skeleton|C1266909|[bdsy]|["Bone"-tx-1-"BONING"-noun-0]|TX|63/6|
00000000|MMI|2.87|Show|C1547282|[anim]|["Show"-tx-33-"showed"-verb-0]|TX|5449/6|
00000000|MMI|2.87|Skeletal bone|C0262950|[bpoc]|["BONE"-tx-1-"BONING"-noun-0]|TX|63/6|
00000000|MMI|2.87|suggestion|C1705535|[idcn]|["Suggest"-tx-39-"suggested"-verb-0]|TX|6287/9|
00000000|MMI|2.73|Liquid diet|C0301571|[topp]|["Fluid diet"-tx-21-"Fluid DIET"-noun-0]|TX|2240/5,2258/4|
00000000|MMI|2.71|Renal dysfunction|C3279454|[fndg]|["Renal dysfunction"-tx-22-"renal dysfunction"-noun-0]|TX|3140/17|
00000000|MMI|2.71|axis deviation|C0262387|[fndg]|["AXIS DEVIATION"-tx-29-"axis deviation"-noun-0]|TX|4958/14|
00000000|MMI|2.70|Lobectomy of lung|C0189497|[topp]|["lung lobectomy"-tx-22-"lung lobectomy"-noun-0]|TX|2999/4,3011/9|
00000000|MMI|2.68|aspirin enteric coated|C0718690|[orch,phsu]|["enteric coated aspirin"-tx-5-"ENTERIC COATED ASPIRIN"-noun-0]|TX|544/22|
00000000|MMI|2.68|Relieved by|C0332303|[ftcn]|["Relieved by"-tx-23-"relieved by"-verb-0]|TX|3723/11|
00000000|MMI|2.66|% volume (qualifier value)|C1690016|[qlco]|["% volume"-tx-35-"volume"-noun-0]|TX|5927/6|
00000000|MMI|2.66|Character String Data Type|C3272372|[inpr]|["ST"-tx-31-"ST"-noun-0]|TX|5338/2|
00000000|MMI|2.66|Chemical extraction|C0684295|[lbpr]|["extraction"-tx-39-"extraction"-noun-0]|TX|6306/10|
00000000|MMI|2.66|Clinical trial protocol document|C1507394|[inpr]|["Prot"-tx-29-"prot"-noun-0]|TX|4876/4|
00000000|MMI|2.66|Coating (film)|C1522408|[qlco]|["Coated"-tx-5-"COATED"-adj-0]|TX|585/6|
00000000|MMI|2.66|Electrocardiogram: left bundle branch block (finding)|C0344420|[lbtr]|["LBBB"-tx-29-"LBBB"-noun-0]|TX|4942/4|
00000000|MMI|2.66|Enteral|C1304890|[spco]|["Enteric"-tx-5-"ENTERIC"-adj-0]|TX|577/7|
00000000|MMI|2.66|Extraction|C0185115|[topp]|["Extraction"-tx-39-"extraction"-noun-0]|TX|6306/10|
00000000|MMI|2.66|Gari (substance)|C0458974|[food]|["gary"-tx-1-"GARY"-noun-0]|TX|266/4|
00000000|MMI|2.66|Left atrial hypertrophy|C0238705|[anab]|["LAE"-tx-28-"LAE"-noun-0]|TX|4649/3|
00000000|MMI|2.66|MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME|C3280240|[dsyn]|["MEDS"-tx-27-"MEDS"-noun-0]|TX|4189/4|
00000000|MMI|2.66|Medical Examination|C0582103|[hlca]|["Exam"-tx-27-"EXAM"-noun-0]|TX|4423/4|
00000000|MMI|2.66|Moderate intensity|C4081855|[clas]|["Moderate intensity"-tx-29-"moderate intensity"-noun-0]|TX|4820/18|
00000000|MMI|2.66|SLC6A7 gene|C1420218|[gngm]|["PROT"-tx-29-"prot"-noun-0]|TX|4876/4|
00000000|MMI|2.66|Status|C0449438|[qlco]|["Status"-tx-2-"STATUS"-noun-0]|TX|283/6|
00000000|MMI|2.66|TXNRD1 wt Allele|C3811249|[gngm]|["TR"-tx-28-"TR"-noun-0]|TX|4685/2|
00000000|MMI|2.66|TXNRD2 wt Allele|C3811250|[gngm]|["TR"-tx-28-"TR"-noun-0]|TX|4685/2|
00000000|MMI|2.66|Thioredoxin Reductase 1, Cytoplasmic|C3814410|[aapp,enzy]|["TR"-tx-28-"TR"-noun-0]|TX|4685/2|
00000000|MMI|2.66|Total protein measurement|C0555903|[lbpr]|["PROT"-tx-29-"prot"-noun-0]|TX|4876/4|
00000000|MMI|2.66|Tumor Results Domain|C3814152|[inpr]|["TR"-tx-28-"TR"-noun-0]|TX|4685/2|
00000000|MMI|2.66|Volume|C0449468|[qnco]|["*Volume"-tx-35-"volume"-noun-0]|TX|5927/6|
00000000|MMI|2.66|Volume (publication)|C1705102|[inpr]|["Volume"-tx-35-"volume"-noun-0]|TX|5927/6|
00000000|MMI|2.66|Volume Measurement|C2700258|[lbpr]|["Volume"-tx-35-"volume"-noun-0]|TX|5927/6|
00000000|MMI|2.66|buying|C0870238|[socb]|["Buy"-tx-41-"buy"-noun-0]|TX|6516/3|
00000000|MMI|2.65|Principal Diagnosis:-:Point in time:^Patient:-|C2598194|[clna]|["Principal Diagnosis"-tx-22-"PRINCIPAL DIAGNOSIS"-noun-0]|TX|2602/9,2622/9|
00000000|MMI|2.65|Principal diagnosis|C0332137|[qlco]|["Principal Diagnosis"-tx-22-"PRINCIPAL DIAGNOSIS"-noun-0]|TX|2602/9,2622/9|
00000000|MMI|2.63|Dose number|C1115464|[qnco]|["Dose number"-tx-17-"Number Doses"-noun-0]|TX|1878/6,1888/5|
00000000|MMI|2.63|CR2 gene|C1413696|[gngm]|["CR2"-tx-26-"Cr 2"-noun-0]|TX|4131/4|
00000000|MMI|2.63|Complement Receptor Type 2|C3539605|[aapp,rcpt]|["Cr2"-tx-26-"Cr 2"-noun-0]|TX|4131/4|
00000000|MMI|2.63|TDGF1P2 gene|C3469967|[gngm]|["CR-2"-tx-26-"Cr 2"-noun-0]|TX|4131/4|
00000000|MMI|2.63|discharge diagnosis|C1555319|[fndg]|["Discharge diagnosis"-tx-22-"DISCHARGE DIAGNOSIS"-noun-0]|TX|2612/19|
00000000|MMI|2.63|Entered|C1521975|[qlco]|["Entered"-tx-52-"ENTERED"-verb-0]|TX|7759/7|
00000000|MMI|2.63|Soft Tissue Route of Drug Administration|C1522192|[ftcn]|["SOFT TISSUE"-tx-29-"soft tissue"-noun-0]|TX|4796/11|
00000000|MMI|2.63|Use of|C1524063|[ftcn]|["Use of"-tx-52-"use of"-noun-0]|TX|7603/6|
00000000|MMI|2.63|soft tissue|C0225317|[tisu]|["Soft Tissue"-tx-29-"soft tissue"-noun-0]|TX|4796/11|
00000000|MMI|2.62|Act Relationship Subset - previous|C1552607|[tmco]|["previous"-tx-14-"Previous"-adj-0]|TX|1488/8|
00000000|MMI|2.62|Basic Metabolic Panel Blood Test|C2237045|[lbpr]|["Chem 7"-tx-29-"chem 7"-noun-0]|TX|5073/6|
00000000|MMI|2.62|Disposition|C0743223|[idcn]|["Disposition"-tx-2-"DISPOSITION"-noun-0]|TX|301/11|
00000000|MMI|2.62|Disposition Domain|C1705555|[inpr]|["Disposition"-tx-2-"DISPOSITION"-noun-0]|TX|301/11|
00000000|MMI|2.62|Hong Kong Zebrafish|C2987742|[fish]|["HK"-tx-28-"HK"-noun-0]|TX|4639/2|
00000000|MMI|2.62|KNG1 gene|C1537501|[gngm]|["HK"-tx-28-"HK"-noun-0]|TX|4639/2|
00000000|MMI|2.62|KNG1 wt Allele|C1705889|[gngm]|["HK"-tx-28-"HK"-noun-0]|TX|4639/2|
00000000|MMI|2.62|Previous|C0205156|[tmco]|["Previous"-tx-14-"Previous"-adj-0]|TX|1488/8|
00000000|MMI|2.62|Scientific Study|C0947630|[lbpr]|["studies"-tx-28-"STUDIES"-noun-0]|TX|4563/7|
00000000|MMI|2.61|TE06|C1515148|[cell]|["I 6"-tx-29-"I/6"-noun-0]|TX|5013/3|
00000000|MMI|2.61|Episode of|C0332189|[tmco]|["Episode of"-tx-22-"episodes of"-noun-0]|TX|3651/11|
00000000|MMI|2.61|*Activity (kind of quantity)|C1561536|[idcn]|["*Activity"-tx-21-"ACTIVITY"-noun-0]|TX|2345/8|
00000000|MMI|2.61|Active|C0205177|[ftcn]|["Activity"-tx-21-"ACTIVITY"-noun-0]|TX|2345/8|
00000000|MMI|2.61|Activities|C0441655|[acty]|["ACTIVITY"-tx-21-"ACTIVITY"-noun-0]|TX|2345/8|
00000000|MMI|2.61|Activity (animal life circumstance)|C3668946|[fndg]|["Activity"-tx-21-"ACTIVITY"-noun-0]|TX|2345/8|
00000000|MMI|2.61|Adult female goat|C3668950|[mamm]|["Doe"-tx-25-"DOE"-noun-0]|TX|3892/3|
00000000|MMI|2.61|Department of Energy|C1511776|[prog]|["DOE"-tx-25-"DOE"-noun-0]|TX|3892/3|
00000000|MMI|2.61|Dyspnea on exertion|C0231807|[sosy]|["DOE"-tx-25-"DOE"-noun-0]|TX|3892/3|
00000000|MMI|2.61|ETV3 gene|C0812270|[gngm]|["METS"-tx-31-"mets"-noun-0]|TX|5322/4|
00000000|MMI|2.61|ETV3 wt Allele|C1705694|[gngm]|["METS"-tx-31-"mets"-noun-0]|TX|5322/4|
00000000|MMI|2.61|FDA Establishment Activity Terminology|C4049939|[inpr]|["ACTIVITY"-tx-21-"ACTIVITY"-noun-0]|TX|2345/8|
00000000|MMI|2.61|Impression|C1998467|[qlco]|["Impression"-tx-29-"IMPRESSION"-noun-0]|TX|5117/10|
00000000|MMI|2.61|Metastatic Neoplasm|C2939420|[neop]|["mets"-tx-31-"mets"-noun-0]|TX|5322/4|
00000000|MMI|2.61|Percent Activity|C0439167|[qnco]|["% Activity"-tx-21-"ACTIVITY"-noun-0]|TX|2345/8|
00000000|MMI|2.61|Physical Activity Measurement|C4049938|[lbpr]|["ACTIVITY"-tx-21-"ACTIVITY"-noun-0]|TX|2345/8|
00000000|MMI|2.61|Planned|C1301732|[ftcn]|["Plan"-tx-51-"PLAN"-noun-0]|TX|7417/4|
00000000|MMI|2.61|Radiologic Impression|C4049863|[fndg]|["Impression"-tx-29-"IMPRESSION"-noun-0]|TX|5117/10|
00000000|MMI|2.61|Superior segmental vein|C0507239|[bpoc]|["V6"-tx-29-"v6"-noun-0]|TX|5002/2|
00000000|MMI|2.61|Treatment Plan|C0599880|[inpr]|["Plan"-tx-51-"PLAN"-noun-0]|TX|7417/4|
00000000|MMI|2.61|impression (attitude)|C0596764|[inbe]|["impression"-tx-29-"IMPRESSION"-noun-0]|TX|5117/10|
00000000|MMI|2.60|Renal artery stent|C1322812|[medd]|["Renal artery stent"-tx-22-"renal artery stent"-noun-0]|TX|3160/12,3188/5|
00000000|MMI|2.60|Stenting|C2348535|[topp]|["Stenting"-tx-26-"stenting"-noun-0]|TX|4071/8|
00000000|MMI|2.60|Fluid behavior|C0444611|[qlco]|["Fluid"-tx-45-"fluid"-noun-0]|TX|6888/5|
00000000|MMI|2.60|Liquid substance|C0302908|[sbst]|["fluid"-tx-45-"fluid"-noun-0]|TX|6888/5|
00000000|MMI|2.60|Receive|C1514756|[qlco]|["RECEIVED"-tx-39-"received"-adj-0]|TX|6342/8|
00000000|MMI|2.60|Saint Helena Islands|C0038108|[geoa]|["SH"-tx-27-"SH"-noun-0]|TX|4380/2|
00000000|MMI|2.60|Today|C0310367|[antb,orch]|["Today"-tx-7-"Today"-noun-0]|TX|868/5|
00000000|MMI|2.60|Today (temporal qualifier)|C0750526|[tmco]|["Today"-tx-7-"Today"-noun-0]|TX|868/5|
00000000|MMI|2.60|film (photographic)|C0086296|[mnob]|["films"-tx-39-"films"-noun-0]|TX|6358/5|
00000000|MMI|2.60|fluid - substance|C1704353|[sbst]|["Fluid"-tx-45-"fluid"-noun-0]|TX|6888/5|
00000000|MMI|2.59|97|C0439073|[inpr]|["97"-tx-27-"97"-integer-0]|TX|4434/2|
00000000|MMI|2.59|>97|C0439082|[qnco]|[">97"-tx-27-"97"-integer-0]|TX|4434/2|
00000000|MMI|2.59|ActInformationPrivacyReason <service>|C3245478|[idcn]|["service"-tx-1-"Service"-noun-0]|TX|97/7|
00000000|MMI|2.59|HPS4 gene|C1423767|[gngm]|["LE"-tx-29-"le"-noun-0]|TX|4891/2|
00000000|MMI|2.59|LE, Rat Strain|C2697858|[mamm]|["LE"-tx-29-"le"-noun-0]|TX|4891/2|
00000000|MMI|2.59|Less Than or Equal to|C0439090|[qnco]|["LE"-tx-29-"le"-noun-0]|TX|4891/2|
00000000|MMI|2.59|Pediculus humanus capitis (eukaryote)|C0411280|[euka]|["Nit, NOS"-tx-29-"nit"-noun-0]|TX|4887/3|
00000000|MMI|2.59|Percent in White Blood Count Differential|C1882326|[qnco]|["% WBC"-tx-29-"wbc"-noun-0]|TX|4894/3|
00000000|MMI|2.59|Plain chest X-ray|C0039985|[diap]|["cxr"-tx-29-"CXR"-noun-0]|TX|5017/3|
00000000|MMI|2.59|Services|C0557854|[ocac]|["Service"-tx-1-"Service"-noun-0]|TX|97/7|
00000000|MMI|2.59|Software Service|C2825316|[mnob]|["Service"-tx-1-"Service"-noun-0]|TX|97/7|
00000000|MMI|2.59|FABP6 protein, human|C1435727|[aapp,bacs]|["GT"-tx-29-"gt"-noun-0]|TX|4756/2|
00000000|MMI|2.59|Cover (physical object)|C3888055|[mnob]|["Cover"-tx-52-"cover"-verb-0]|TX|7683/5|
00000000|MMI|2.59|Cover - action|C1999244|[ftcn]|["Cover"-tx-52-"cover"-verb-0]|TX|7683/5|
00000000|MMI|2.59|Cover Device Component|C1707529|[medd]|["Cover"-tx-52-"cover"-verb-0]|TX|7683/5|
00000000|MMI|2.59|Covers (device)|C0180153|[medd]|["cover"-tx-52-"cover"-verb-0]|TX|7683/5|
00000000|MMI|2.59|DENTAL EVALUATION|C0011356|[diap]|["DENTAL EVALUATION"-tx-39-"dental evaluation"-noun-0]|TX|6269/17|
00000000|MMI|2.59|End|C0444930|[spco]|["End"-tx-55-"END"-noun-0]|TX|7843/3|
00000000|MMI|2.59|Inferior|C0542339|[spco]|["INFERIOR"-tx-31-"inferior"-adj-0]|TX|5352/8|
00000000|MMI|2.59|Patient Outcome - Worsening|C1546960|[idcn]|["Worsening"-tx-50-"worsening"-verb-0]|TX|7360/9|
00000000|MMI|2.59|Quantity Final Containers Returned|C3714905|[qnco]|["Returned"-tx-36-"returned"-verb-0]|TX|6054/8|
00000000|MMI|2.59|Responsible to|C1273518|[fndg]|["Responsible"-tx-22-"Responsible"-adj-0]|TX|2633/11|
00000000|MMI|2.59|Return to (contextual qualifier) (qualifier value)|C0332156|[qlco]|["Returned"-tx-36-"returned"-verb-0]|TX|6054/8|
00000000|MMI|2.59|Stop (qualifier value)|C2746065|[tmco]|["End"-tx-55-"END"-noun-0]|TX|7843/3|
00000000|MMI|2.59|Surgical transfer - action|C0348011|[ftcn]|["transferred"-tx-24-"transferred"-verb-0]|TX|3813/11|
00000000|MMI|2.59|Symptoms|C1457887|[sosy]|["SYMPTOMS"-tx-50-"symptoms"-noun-0]|TX|7373/8|
00000000|MMI|2.59|Symptoms aspect|C0683368|[ftcn]|["symptoms"-tx-50-"symptoms"-noun-0]|TX|7373/8|
00000000|MMI|2.59|Transfer Technique|C1705822|[ftcn]|["Transferred"-tx-24-"transferred"-verb-0]|TX|3813/11|
00000000|MMI|2.59|Worse|C1457868|[fndg]|["Worsening"-tx-50-"worsening"-verb-0]|TX|7360/9|
00000000|MMI|2.59|Worsening pattern|C0332271|[qlco]|["Worsening"-tx-50-"worsening"-verb-0]|TX|7360/9|
00000000|MMI|2.59|inferiority|C0678975|[socb]|["inferior"-tx-31-"inferior"-adj-0]|TX|5352/8|
00000000|MMI|2.59|ADK gene|C1412243|[gngm]|["AK"-tx-28-"AK"-noun-0]|TX|4618/2|
00000000|MMI|2.58|Dental surgical procedure|C0204324|[topp]|["dental surgery"-tx-39-"surgery dental"-noun-0]|TX|6261/14|
00000000|MMI|2.58|Increased metabolic requirement|C0520917|[patf]|["Increased requirement"-tx-22-"requirements increased"-noun-0]|TX|3605/12,3623/9|
00000000|MMI|2.58|anginal equivalent|C0741034|[sosy]|["anginal equivalent"-tx-25-"anginal equivalent"-noun-0]|TX|3917/18|
00000000|MMI|2.58|Anterior descending branch of left coronary artery|C0226032|[bpoc]|["Left anterior descending artery"-tx-33-"Left Anterior Descending Artery"-noun-0]|TX|5520/31|
00000000|MMI|2.57|Assessed|C1516048|[acty]|["Assessed"-tx-39-"assessed"-verb-0]|TX|6201/8|
00000000|MMI|2.57|Breath|C0225386|[bdsu]|["Breath"-tx-41-"breath"-noun-0]|TX|6579/6|
00000000|MMI|2.57|Course|C0750729|[tmco]|["Course"-tx-30-"COURSE"-noun-0]|TX|5233/6|
00000000|MMI|2.57|Empty (qualifier)|C1880497|[qlco]|["Empty"-tx-16-"empty"-adj-0]|TX|1863/5|
00000000|MMI|2.57|Entire stomach|C1278920|[bpoc]|["Stomach"-tx-16-"stomach"-noun-0]|TX|1869/7|
00000000|MMI|2.57|Gastric Tissue|C1517454|[tisu]|["STOMACH"-tx-16-"stomach"-noun-0]|TX|1869/7|
00000000|MMI|2.57|Limited Lifting Ability|C4050251|[inpr]|["Limited"-tx-29-"limited"-verb-0]|TX|4785/7|
00000000|MMI|2.57|Limited Walking Ability|C2674459|[fndg]|["Limited"-tx-29-"limited"-verb-0]|TX|4785/7|
00000000|MMI|2.57|Limited component (foundation metadata concept)|C3542948|[inpr]|["Limited"-tx-29-"limited"-verb-0]|TX|4785/7|
00000000|MMI|2.57|Out (direction)|C0439787|[spco]|["Out"-tx-30-"out"-adv-0]|TX|5299/3|
00000000|MMI|2.57|Present|C0150312|[qnco]|["Present"-tx-50-"present"-noun-0]|TX|7333/7|
00000000|MMI|2.57|R prime|C2603358|[clna]|["R'"-tx-22-"R"-noun-0]|TX|3338/1|
00000000|MMI|2.57|Removed|C0849355|[qlco]|["Out"-tx-30-"out"-adv-0]|TX|5299/3|
00000000|MMI|2.57|Right|C0205090|[spco]|["R-"-tx-22-"R"-noun-0]|TX|3338/1|
00000000|MMI|2.57|Short|C1806781|[qnco]|["Short"-tx-41-"short"-prep-0]|TX|6570/5|
00000000|MMI|2.57|Short Value|C2350002|[qnco]|["Short"-tx-41-"short"-prep-0]|TX|6570/5|
00000000|MMI|2.57|Stomach structure|C3714551|[bpoc]|["Stomach"-tx-16-"stomach"-noun-0]|TX|1869/7|
00000000|MMI|2.57|subscriber - self|C1551994|[inpr]|["self"-tx-41-"self"-noun-0]|TX|6547/4|
00000000|MMI|2.57|Prophylactic treatment|C0199176|[topp]|["Prophylaxis"-tx-52-"prophylaxis"-noun-0]|TX|7704/11|
00000000|MMI|2.57|Scheduled - procedure status|C0205539|[qlco]|["scheduling"-tx-40-"scheduling"-noun-0]|TX|6473/10|
00000000|MMI|2.57|Scheduling (procedure)|C1446911|[hlca]|["Scheduling"-tx-40-"scheduling"-noun-0]|TX|6473/10|
00000000|MMI|2.57|Therapeutic|C0302350|[ftcn]|["Therapeutic"-tx-46-"therapeutic"-adj-0]|TX|6942/11|E02
00000000|MMI|2.57|prophylaxis - ActNonObservationIndicationCode|C3853787|[topp]|["prophylaxis"-tx-52-"prophylaxis"-noun-0]|TX|7704/11|
00000000|MMI|2.56|Discussion (communication)|C2584313|[socb]|["Discuss"-tx-43-"Discussed"-verb-0]|TX|6823/9|
00000000|MMI|2.56|Allopathic & Osteopathic Physicians - Surgery|C3853799|[prog]|["Surgery"-tx-39-"surgery"-noun-0]|TX|6261/7|
00000000|MMI|2.56|Conditional|C1701901|[qlco]|["Contingent"-tx-1-"CONTINGENT"-noun-0]|TX|152/10|
00000000|MMI|2.56|Operative Surgical Procedures|C0543467|[hlca]|["Surgery"-tx-39-"surgery"-noun-0]|TX|6261/7|E04
00000000|MMI|2.56|Surgery specialty|C0038894|[bmod]|["Surgery"-tx-39-"surgery"-noun-0]|TX|6261/7|
00000000|MMI|2.56|Used by|C1273517|[fndg]|["used"-tx-1-"USED"-verb-0]|TX|207/4|
00000000|MMI|2.56|Stenosis (invertebrate)|C2632116|[euka]|["Stenosis"-tx-22-"stenosis"-noun-0]|TX|3173/8|
00000000|MMI|2.56|Stenosis Morphology|C0678234|[qlco]|["Stenosis"-tx-22-"stenosis"-noun-0]|TX|3173/8|
00000000|MMI|2.55|Basal Cell|C0596155|[cell]|["Basal Cell"-tx-22-"basal cell"-noun-0]|TX|3087/10|
00000000|MMI|2.55|Fluid restriction|C0204700|[topp]|["Fluid restriction"-tx-21-"Fluid restriction"-noun-0]|TX|2240/17|
00000000|MMI|2.53|Scheduled surgical procedure|C3845500|[fndg]|["Scheduled Surgery"-tx-21-"scheduled Surgery"-noun-0]|TX|2467/9,2482/7|
00000000|MMI|2.53|Abnormally high|C1299351|[qlco]|["High"-tx-26-"high"-adj-0]|TX|4030/4|
00000000|MMI|2.53|Causing|C0678227|[ftcn]|["Causing"-tx-22-"Causing"-adj-0]|TX|2661/7|
00000000|MMI|2.53|DNR - Do not resuscitate|C0582114|[fndg]|["DNR"-tx-47-"DNR"-noun-0]|TX|7135/3|
00000000|MMI|2.53|Diagnosis Type - Final|C1546485|[idcn]|["Final"-tx-1-"FINAL"-adj-0]|TX|33/5|
00000000|MMI|2.53|Document Completion - incomplete|C1548386|[idcn]|["Incomplete"-tx-29-"incomplete"-adj-0]|TX|4931/10|
00000000|MMI|2.53|End-stage|C0205088|[qlco]|["Final"-tx-1-"FINAL"-adj-0]|TX|33/5|
00000000|MMI|2.53|Final|C3853528|[tmco]|["Final"-tx-1-"FINAL"-adj-0]|TX|33/5|
00000000|MMI|2.53|Flat shape|C0205324|[spco]|["Flat"-tx-25-"flat"-adj-0]|TX|3868/4|
00000000|MMI|2.53|High|C0205250|[qlco]|["High"-tx-26-"high"-adj-0]|TX|4030/4|
00000000|MMI|2.53|High Mitosis-Karyorrhexis Index|C3889660|[qnco]|["High"-tx-26-"high"-adj-0]|TX|4030/4|
00000000|MMI|2.53|Incomplete|C0205257|[qnco]|["INCOMPLETE"-tx-29-"incomplete"-adj-0]|TX|4931/10|
00000000|MMI|2.53|Minimum|C1524031|[qlco]|["Trace"-tx-28-"trace"-noun-0]|TX|4679/5|
00000000|MMI|2.53|Partial|C0728938|[qnco]|["incomplete"-tx-29-"incomplete"-adj-0]|TX|4931/10|
00000000|MMI|2.53|Possible|C0332149|[qlco]|["Possible"-tx-39-"possible"-adj-0]|TX|6297/8|
00000000|MMI|2.53|Possible diagnosis|C2362652|[qlco]|["Possible"-tx-39-"possible"-adj-0]|TX|6297/8|
00000000|MMI|2.53|Possibly Related to Intervention|C1705910|[qlco]|["Possible"-tx-39-"possible"-adj-0]|TX|6297/8|
00000000|MMI|2.53|Residential flat|C0457933|[mnob]|["Flat"-tx-25-"flat"-adj-0]|TX|3868/4|
00000000|MMI|2.53|Sequence Chromatogram|C1883002|[ftcn]|["Trace"-tx-28-"trace"-noun-0]|TX|4679/5|
00000000|MMI|2.53|Sinus - general anatomical term|C1305231|[bsoj]|["SINUS"-tx-29-"sinus"-noun-0]|TX|4917/5|
00000000|MMI|2.53|Value Above Reference Range|C2700149|[inpr]|["HIGH"-tx-26-"high"-adj-0]|TX|4030/4|
00000000|MMI|2.53|Yes (indicator)|C1705108|[cnce]|["YES"-tx-1-"YES"-noun-0]|TX|232/3|
00000000|MMI|2.53|Yes - Yes/no indicator|C1549445|[idcn]|["Yes"-tx-1-"YES"-noun-0]|TX|232/3|
00000000|MMI|2.53|dictated - DocumentCompletion|C1609990|[idcn]|["Dictated"-tx-52-"dictated"-adj-0]|TX|7742/8|
00000000|MMI|2.53|dictated - ParticipationMode|C1548384|[ftcn]|["dictated"-tx-52-"dictated"-adj-0]|TX|7742/8|
00000000|MMI|2.53|high - ActExposureLevelCode|C3887512|[idcn]|["high"-tx-26-"high"-adj-0]|TX|4030/4|
00000000|MMI|2.53|trace amount|C0442822|[qnco]|["Trace"-tx-28-"trace"-noun-0]|TX|4679/5|
00000000|MMI|2.52|Lisinopril 2.5 MG|C0987218|[clnd]|["Lisinopril 2.5 MG"-tx-10-"LISINOPRIL 2.5 MG"-noun-0]|TX|1103/17|
00000000|MMI|2.52|mg/mg|C1319635|[qnco]|["mg/mg"-tx-21-"MG MG"-noun-0]|TX|2200/2,2224/2|
00000000|MMI|2.52|Allopurinol 100 MG|C0983478|[clnd]|["Allopurinol 100 MG"-tx-2-"ALLOPURINOL 100 MG"-noun-0]|TX|354/18|
00000000|MMI|2.52|Right coronary artery structure|C1261316|[bpoc]|["Right Coronary Artery"-tx-33-"Right Coronary Artery"-noun-0]|TX|5645/21|
00000000|MMI|2.51|Structure of circumflex branch of left coronary artery|C0226037|[bpoc]|["Left circumflex artery"-tx-33-"Left Circumflex Artery"-noun-0]|TX|5590/22|
00000000|MMI|2.51|Long|C0205166|[qlco]|["Long"-tx-35-"longer"-adj-0]|TX|5920/6|
00000000|MMI|2.51|Long Variable|C1706317|[qlco]|["Long"-tx-35-"longer"-adj-0]|TX|5920/6|
00000000|MMI|2.51|Administration procedure|C1533734|[topp]|["Treatment"-tx-22-"Treatment"-noun-0]|TX|2771/9|
00000000|MMI|2.51|Aggressive course|C0580822|[tmco]|["Aggressive"-tx-46-"Aggressive"-adj-0]|TX|6904/10|
00000000|MMI|2.51|Anticipated|C3840775|[fndg]|["Anticipated"-tx-46-"anticipated"-adj-0]|TX|7077/11|
00000000|MMI|2.51|Biomaterial Treatment|C1705169|[cnce]|["Treatment"-tx-22-"Treatment"-noun-0]|TX|2771/9|
00000000|MMI|2.51|CDISC SEND Severity Terminology|C2983285|[inpr]|["SEV"-tx-29-"sev"-noun-0]|TX|5149/3|
00000000|MMI|2.51|Card (document)|C3275277|[inpr]|["Card"-tx-21-"CARD"-noun-0]|TX|2407/4|
00000000|MMI|2.51|Creatinine finding|C1561535|[fndg]|["Creatinine"-tx-42-"creatinine"-noun-1]|TX|6731/10|
00000000|MMI|2.51|Degree Unit of Plane Angle|C2348088|[qnco]|["Deg"-tx-29-"deg"-noun-0]|TX|4979/3|
00000000|MMI|2.51|Event Seriousness - Significant|C1546944|[qlco]|["Significant"-tx-33-"significant"-adj-0]|TX|5486/11|
00000000|MMI|2.51|Followed by|C0332283|[tmco]|["followed"-tx-42-"followed"-adj-0]|TX|6722/8|
00000000|MMI|2.51|K Prime|C1708601|[qnco]|["K'"-tx-46-"K"-noun-0]|TX|6915/1|
00000000|MMI|2.51|P Blood group antibodies|C0369773|[aapp,imft]|["P NOS"-tx-23-"p"-adj-0]|TX|3695/1|
00000000|MMI|2.51|P prime|C2603361|[clna]|["P'"-tx-23-"p"-adj-0]|TX|3695/1|
00000000|MMI|2.51|Pairing Events Domain|C3541314|[inpr]|["PA"-tx-28-"PA"-noun-0]|TX|4690/2|
00000000|MMI|2.51|Potassium Ion|C0597277|[elii,phsu]|["K+"-tx-46-"K"-noun-0]|TX|6915/1|
00000000|MMI|2.51|Regular exercise (observable entity)|C0582191|[dora]|["Regular exercise"-tx-21-"regular exercise"-noun-0]|TX|2362/16|
00000000|MMI|2.51|Sev (substance)|C0458216|[food]|["Sev"-tx-29-"sev"-noun-0]|TX|5149/3|
00000000|MMI|2.51|Severities|C0439793|[qlco]|["SEV"-tx-29-"sev"-noun-0]|TX|5149/3|
00000000|MMI|2.51|Significant|C0750502|[idcn]|["Significant"-tx-33-"significant"-adj-0]|TX|5486/11|
00000000|MMI|2.51|Statistical Significance|C0237881|[qnco]|["significant"-tx-33-"significant"-adj-0]|TX|5486/11|
00000000|MMI|2.51|Surrounding (qualifier value)|C1282914|[spco]|["Surrounding"-tx-28-"surrounding"-adj-0]|TX|4627/11|
00000000|MMI|2.51|Treating|C1522326|[ftcn]|["Treatment"-tx-22-"Treatment"-noun-0]|TX|2771/9|
00000000|MMI|2.51|Treatment Epoch|C3538994|[resa]|["TREATMENT"-tx-22-"Treatment"-noun-0]|TX|2771/9|
00000000|MMI|2.51|Units Of Measure - lumen|C1551056|[qnco]|["lm"-tx-33-"LM"-noun-0]|TX|5498/2|
00000000|MMI|2.51|chronic|C0205191|[tmco]|["CHRONIC"-tx-22-"chronic"-adj-0]|TX|3132/7|
00000000|MMI|2.51|treatment - ActInformationManagementReason|C3887704|[hlca]|["treatment"-tx-22-"Treatment"-noun-0]|TX|2771/9|
00000000|MMI|2.50|0/5|C0444499|[qnco]|["0/5"-tx-17-"0.5"-real_number-0]|TX|1967/3|
00000000|MMI|2.50|Central|C0205099|[spco]|["CENTRAL"-tx-28-"central"-adj-0]|TX|4666/7|
00000000|MMI|2.50|Central Minus|C1879652|[lbpr]|["Central -"-tx-28-"central"-adj-0]|TX|4666/7|
00000000|MMI|2.50|Large|C0549177|[qnco]|["LARGE"-tx-29-"large"-adj-0]|TX|4810/5|
00000000|MMI|2.50|Sodium Cation|C0597484|[elii]|["Sodium+"-tx-21-"Sodium"-noun-0]|TX|2338/6|
00000000|MMI|2.50|Sodium Drug Class|C3714642|[phsu]|["SODIUM"-tx-21-"Sodium"-noun-0]|TX|2338/6|
00000000|MMI|2.50|Sodium supplements|C3541959|[phsu]|["Sodium"-tx-21-"Sodium"-noun-0]|TX|2338/6|
00000000|MMI|2.50|Stops device|C0450446|[mnob]|["Stops"-tx-25-"stops"-noun-0]|TX|3882/5|
00000000|MMI|2.50|Vanadium 5+|C2349105|[elii]|["V5+"-tx-29-"v5"-noun-0]|TX|4999/2|
00000000|MMI|2.50|gram|C0439208|[qnco]|["GRAM"-tx-21-"gram"-noun-0]|TX|2333/4|
00000000|MMI|2.50|Increasing breathlessness|C0574066|[sosy]|["Increased Dyspnoea"-tx-22-"increased dyspnea"-noun-0]|TX|3623/17|
00000000|MMI|2.50|Unknown (origin) (qualifier value)|C0332240|[ftcn]|["unknown origin"-tx-35-"unknown origin"-noun-0]|TX|5902/14|
00000000|MMI|2.50|Basal|C0205112|[spco]|["BASAL"-tx-29-"basal"-adj-0]|TX|4845/5|
00000000|MMI|2.50|GIF gene|C1415066|[gngm]|["INF"-tx-29-"inf"-noun-0]|TX|4851/3|
00000000|MMI|2.50|Prior Medication Usage|C2826257|[evnt]|["PRIOR"-tx-51-"prior"-adj-0]|TX|7440/5|
00000000|MMI|2.50|Teaching principal|C0401925|[prog]|["Principal"-tx-22-"PRINCIPAL"-adj-0]|TX|2602/9|
00000000|MMI|2.49|CA8 gene|C1413051|[gngm]|["CALS"-tx-21-"cals"-noun-0]|TX|2317/4|
00000000|MMI|2.49|Cardiac - anatomy qualifier|C1522601|[spco]|["Cardiac"-tx-45-"cardiac"-adj-0]|TX|6865/7|
00000000|MMI|2.49|Every evening|C0585330|[tmco]|["QPM"-tx-27-"qpm"-noun-0]|TX|4376/3|
00000000|MMI|2.49|Every morning|C0585329|[tmco]|["QAM"-tx-27-"qam"-noun-0]|TX|4369/3|
00000000|MMI|2.49|Nutrition, Calories|C1556156|[qnco]|["cals"-tx-21-"cals"-noun-0]|TX|2317/4|
00000000|MMI|2.49|Once a day, in the evening|C1275568|[tmco]|["qPM"-tx-27-"qpm"-noun-0]|TX|4376/3|
00000000|MMI|2.49|Study Day|C2826182|[tmco]|["DY"-tx-21-"dy"-noun-0]|TX|2322/2|
00000000|MMI|2.49|kilocalorie|C0439259|[qnco]|["Cal"-tx-21-"cals"-noun-0]|TX|2317/4|
00000000|MMI|2.49|microgram|C0439211|[qnco]|["mcg"-tx-7-"MCG"-noun-0]|TX|919/3|
00000000|MMI|2.49|miscellaneous Crenarchaeota group|C3463985|[arch]|["MCG"-tx-7-"MCG"-noun-0]|TX|919/3|
00000000|MMI|2.49|SAT1 protein, human|C2744672|[aapp,enzy]|["SAT"-tx-21-"sat"-noun-0]|TX|2285/3|
00000000|MMI|2.49|SAT1 wt Allele|C1705827|[gngm]|["SAT"-tx-21-"sat"-noun-0]|TX|2285/3|
00000000|MMI|2.49|Bedtime (qualifier value)|C0521112|[tmco]|["Bedtime"-tx-10-"BEDTIME"-noun-0]|TX|1165/7|
00000000|MMI|2.49|60%|C3842585|[fndg]|["60%"-tx-29-"60"-percentage-0]|TX|4718/2|
00000000|MMI|2.49|Regional lung volume|C0231967|[lbtr]|["RLV"-tx-29-"RLV"-noun-0]|TX|4751/3|
00000000|MMI|2.49|Hospital course|C0489547|[fndg]|["Hospital course"-tx-22-"HOSPITAL COURSE"-noun-1]|TX|3364/15|
00000000|MMI|2.49|Hospital course:Finding:Point in time:^Patient:Narrative|C0488549|[clna]|["Hospital course"-tx-22-"HOSPITAL COURSE"-noun-0]|TX|3364/15|
00000000|MMI|2.49|Room of building - Study|C0557651|[mnob]|["Study"-tx-22-"Study"-noun-0]|TX|2651/5|
00000000|MMI|2.49|Study|C2603343|[resa]|["Study"-tx-22-"Study"-noun-0]|TX|2651/5|
00000000|MMI|2.49|Echo (insect)|C1655045|[euka]|["Echo"-tx-28-"ECHO"-noun-0]|TX|4572/4|
00000000|MMI|2.49|Highest|C1522410|[qlco]|["Apex"-tx-28-"apex"-noun-0]|TX|4613/4|
00000000|MMI|2.49|dinoflagellate apex|C3890171|[celc]|["apex"-tx-28-"apex"-noun-0]|TX|4613/4|
00000000|MMI|2.49|ABD tumor staging notation|C0449202|[inpr]|["ABD"-tx-27-"abd"-noun-0]|TX|4512/3|
00000000|MMI|2.49|Absence of Biallelic TCRgamma Deletion|C3811055|[comd]|["ABD"-tx-27-"abd"-noun-0]|TX|4512/3|
00000000|MMI|2.49|Basilar Rales|C0240859|[fndg]|["Rales"-tx-27-"rales"-noun-0]|TX|4479/5|
00000000|MMI|2.49|Benign|C0205183|[qlco]|["BENIGN"-tx-27-"benign"-adj-0]|TX|4516/6|
00000000|MMI|2.49|III (suffix)|C1705160|[qlco]|["III"-tx-27-"iii"-noun-0]|TX|4491/3|
00000000|MMI|2.49|LRRC4B gene|C1537594|[gngm]|["HSM"-tx-27-"HSM"-noun-0]|TX|4508/3|
00000000|MMI|2.49|PSMD2 gene|C1419032|[gngm]|["S2"-tx-27-"s2"-noun-0]|TX|4488/2|
00000000|MMI|2.49|RPS2 gene|C1419718|[gngm]|["S2"-tx-27-"s2"-noun-0]|TX|4488/2|
00000000|MMI|2.49|Roman Numeral III|C0439070|[inpr]|["III"-tx-27-"iii"-noun-0]|TX|4491/3|
00000000|MMI|2.49|S1|C3715215|[fndg]|["S1"-tx-27-"s1"-noun-0]|TX|4485/2|
00000000|MMI|2.49|S2|C3812876|[fndg]|["S2"-tx-27-"s2"-noun-0]|TX|4488/2|
00000000|MMI|2.49|S2 innervation|C1179705|[blor]|["S2"-tx-27-"s2"-noun-0]|TX|4488/2|
00000000|MMI|2.49|Testicular Cancer Serum Markers Test Result S1|C3814877|[lbtr]|["S1"-tx-27-"s1"-noun-0]|TX|4485/2|
00000000|MMI|2.49|Testicular Cancer Serum Markers Test Result S2|C3812875|[lbtr]|["S2"-tx-27-"s2"-noun-0]|TX|4488/2|
00000000|MMI|2.48|CXADR wt Allele|C3540475|[gngm]|["CAR"-tx-1-"CAR"-noun-0]|TX|106/3|
00000000|MMI|2.48|Coxsackievirus and Adenovirus Receptor|C3539542|[aapp]|["CAR"-tx-1-"CAR"-noun-0]|TX|106/3|
00000000|MMI|2.48|Device Component System|C1704459|[mnob]|["System"-tx-30-"SYSTEM"-noun-0]|TX|5243/6|
00000000|MMI|2.48|LIAS gene|C1424272|[gngm]|["LAS"-tx-26-"LAS"-noun-0]|TX|3995/3|
00000000|MMI|2.48|Ligamentous articular strain technique|C1562368|[topp]|["LAS"-tx-26-"LAS"-noun-0]|TX|3995/3|
00000000|MMI|2.48|Main|C1542147|[qlco]|["Main"-tx-37-"Main"-adj-0]|TX|6091/4|
00000000|MMI|2.48|NPPA gene|C1417807|[gngm]|["PND"-tx-22-"PND"-noun-0]|TX|3663/3|
00000000|MMI|2.48|NR1I3 wt Allele|C3811749|[gngm]|["CAR"-tx-1-"CAR"-noun-0]|TX|106/3|
00000000|MMI|2.48|Paroxysmal nocturnal dyspnea|C1956415|[dsyn]|["PND"-tx-22-"PND"-noun-0]|TX|3663/3|
00000000|MMI|2.48|Primary operation|C0439631|[topp]|["Primary"-tx-42-"primary"-adj-0]|TX|6803/7|
00000000|MMI|2.48|Several|C0443302|[qnco]|["Several"-tx-22-"several"-adj-0]|TX|3643/7|
00000000|MMI|2.48|System|C0449913|[ftcn]|["System"-tx-30-"SYSTEM"-noun-0]|TX|5243/6|
00000000|MMI|2.48|System - kit|C1553451|[mnob]|["System"-tx-30-"SYSTEM"-noun-0]|TX|5243/6|
00000000|MMI|2.48|True primary (qualifier value)|C0439612|[tmco]|["Primary"-tx-42-"primary"-adj-0]|TX|6803/7|
00000000|MMI|2.48|oncologist|C0259990|[prog]|["ONCOLOGIST"-tx-42-"oncologist"-noun-0]|TX|6811/10|
00000000|MMI|2.48|1800s|C0681738|[tmco]|["1800s"-tx-21-"1800"-integer-0]|TX|2312/4|
00000000|MMI|2.48|Beginning|C0439659|[tmco]|["Start"-tx-7-"Starting"-adj-0]|TX|859/8|
00000000|MMI|2.48|Lymphotoxin-Alpha, human|C3887647|[aapp,imft]|["LT"-tx-46-"lt"-noun-0]|TX|7017/2|
00000000|MMI|2.48|Palliative|C1285530|[qlco]|["Palliative"-tx-40-"palliative"-adj-0]|TX|6487/10|
00000000|MMI|2.48|Palliative care service|C0587605|[hcro]|["Palliative"-tx-40-"palliative"-adj-0]|TX|6487/10|
00000000|MMI|2.48|Structure of left thigh|C0230426|[bpoc]|["LT"-tx-46-"lt"-noun-0]|TX|7017/2|
00000000|MMI|2.48|majority|C0680220|[socb]|["majority"-tx-46-"majority"-noun-0]|TX|6958/8|
00000000|MMI|2.47|Bronchoalveolar pneumonia|C3671988|[fndg]|["Bronchoalveolar pneumonia"-tx-29-"bronchoalveolar lung"-noun-0]|TX|5177/20|
00000000|MMI|2.47|Collateral|C1948058|[spco]|["Collateral"-tx-29-"collaterals"-noun-0]|TX|4739/11|
00000000|MMI|2.47|Collateral branch of vessel|C1275670|[bpoc]|["Collateral"-tx-29-"collaterals"-noun-0]|TX|4739/11|
00000000|MMI|2.47|vascular stenosis|C0679403|[anab]|["Vessel stenosis"-tx-34-"vessel stenosis"-noun-0]|TX|5850/6,5861/8|
00000000|MMI|2.47|Behavior Rating Inventory of Executive Function|C4050216|[inpr]|["BRIEF"-tx-22-"BRIEF"-adj-0]|TX|3348/5|
00000000|MMI|2.47|Brief|C1879313|[tmco]|["Brief"-tx-22-"BRIEF"-adj-0]|TX|3348/5|
00000000|MMI|2.47|Recent|C0332185|[tmco]|["Recent"-tx-22-"recent"-adj-0]|TX|3489/6|
00000000|MMI|2.47|anticipation|C0679106|[menp]|["anticipation"-tx-51-"anticipation"-noun-0]|TX|7514/12|
00000000|MMI|2.47|day|C0439228|[tmco]|["DAY"-tx-38-"day"-noun-0]|TX|6175/3|
00000000|MMI|2.47|per day|C0439505|[tmco]|["/day"-tx-38-"day"-noun-0]|TX|6175/3|
00000000|MMI|2.47|Dosage|C0178602|[qnco]|["DOSE"-tx-36-"dose"-noun-0]|TX|6017/4|
00000000|MMI|2.47|Entire jaw region|C1273020|[blor]|["Jaw"-tx-25-"jaw"-noun-0]|TX|3946/3|
00000000|MMI|2.47|Episodic|C1455761|[qlco]|["Episodic"-tx-52-"episodic"-adj-0]|TX|7623/8|
00000000|MMI|2.47|Stent Device Component|C1705817|[medd]|["Stent"-tx-22-"stent"-noun-0]|TX|3188/5|
00000000|MMI|2.47|Unit dose|C0869039|[qnco]|["Dose"-tx-36-"dose"-noun-0]|TX|6017/4|
00000000|MMI|2.47|70%|C3842584|[fndg]|["70%"-tx-34-"70"-integer-0]|TX|5813/2|
00000000|MMI|2.47|Groove|C1184482|[bsoj]|["Groove"-tx-34-"groove"-noun-0]|TX|5795/6|
00000000|MMI|2.47|Small|C0700321|[qnco]|["SMAL